Drugs Used to Treat Hypertension Exams

Drugs Used to Treat Hypertension

Experience unlimited access to all questions, exams, video tutorials and study guides. Subscribe now to access all questions.

Study Questions

Practice Exercise 1

Question 1 :

A patient’s blood pressure (BP) is 130/84. The healthcare provider plans to suggest nonpharmacologic methods for the patient. Which should the nurse include in teaching? Select all that apply

A. Stress-reduction techniques B. Starting an exercise program C. Salt restriction D. Smoking cessation E. Diet with increased protein

Explanation

The nurse should include stress reduction, regular exercise, salt restriction, and smoking cessation when teaching nonpharmacologic interventions for a client with mildly elevated blood pressure. These lifestyle modifications are first-line approaches to prevent progression to hypertension and reduce cardiovascular risk.

Rationale for correct answers
A. Stress-reduction techniques: Stress activates the sympathetic nervous system, increasing heart rate and blood pressure. Relaxation methods such as meditation, yoga, or deep-breathing exercises help lower stress and support BP control.
B. Starting an exercise program: Regular physical activity (e.g., brisk walking 30 minutes daily) improves vascular tone, promotes weight control, and reduces systolic and diastolic pressures.
C. Salt restriction: High sodium intake leads to water retention and increased blood volume. Limiting salt to less than 2 grams per day helps decrease BP and improve cardiac workload.
D. Smoking cessation: Nicotine causes vasoconstriction and increases heart rate and BP. Quitting smoking improves endothelial function and overall cardiovascular health.

Rationale for incorrect answer
E. Diet with increased protein: Increasing protein intake does not directly reduce BP and may burden the kidneys if excessive. The focus should be on a balanced, heart-healthy diet such as the DASH plan rich in fruits, vegetables, and low-fat dairy.

Take-home points
• Lifestyle modification is the cornerstone of early hypertension management.
• Salt restriction, exercise, and smoking cessation significantly improve BP control.
• Stress management and healthy diet choices help prevent the need for medication.

Discussion Section

0 Pulse Checks

No comments

Question 2 :

Scenario

A patient arrived at an outpatient clinic for a follow-up visit to determine adequate hypertension control. The patient had recently been started on an ACE inhibitor and a thiazide diuretic after following lifestyle modifications for 10 years.
The patient in the scenario asks the nurse about the difference between primary and secondary hypertension. Which statement by the nurse accurately answers the question?

A. “Primary hypertension accounts for 90% of all clinical cases of high blood pressure and is readily treatable.” B. “It does not matter whether you have primary or secondary hypertension; your treatment plan will be the same.” C. “Primary hypertension causes target organ damage and secondary hypertension causes fast heart rate, as well as high blood pressure.” D. “Primary hypertension is curable, and secondary hypertension is only controllable.”

Explanation

Hypertension can be classified into primary (essential) and secondary types based on its underlying cause. Primary hypertension accounts for the vast majority of cases and has no identifiable cause, though it is associated with factors such as genetics, diet, obesity, and stress. In contrast, secondary hypertension results from an identifiable medical condition such as kidney disease, endocrine disorders, or medication effects. Understanding this distinction helps guide appropriate management and patient education.

Rationale for correct answer:
A. “Primary hypertension accounts for 90% of all clinical cases of high blood pressure and is readily treatable.”
This statement accurately reflects that primary (essential) hypertension makes up about 90–95% of all cases. Although it has no specific cause, it is often effectively managed through lifestyle modifications and antihypertensive medications such as ACE inhibitors and thiazide diuretics. While not curable, it is readily controllable to prevent complications like stroke, heart failure, and renal disease.

Rationales for incorrect answers:
B. “It does not matter whether you have primary or secondary hypertension; your treatment plan will be the same.”
This statement is inaccurate because secondary hypertension requires addressing the underlying cause (e.g., removing an adrenal tumor or treating kidney disease). In contrast, primary hypertension focuses on lifestyle modification and pharmacologic management to control blood pressure.

C. “Primary hypertension causes target organ damage and secondary hypertension causes fast heart rate, as well as high blood pressure.”
Both types can lead to target organ damage (heart, kidneys, brain, eyes) if uncontrolled. However, tachycardia is not a defining feature of secondary hypertension. This statement reflects a misunderstanding of pathophysiology.

D. “Primary hypertension is curable, and secondary hypertension is only controllable.”
The opposite is true. Primary hypertension is not curable but can be controlled. Secondary hypertension, on the other hand, may be curable if the underlying cause (such as renal artery stenosis or endocrine disorder) is corrected.

Take-home points:

Primary hypertension accounts for 90–95% of cases and has no identifiable cause but is treatable and controllable.
Secondary hypertension results from an identifiable cause and may be curable if the cause is corrected.
Proper differentiation between the two types is crucial for individualized management and patient education.

Discussion Section

0 Pulse Checks

No comments

Question 3 :

The nurse reviewing the assessments and interventions for the patient in the scenario who is concerned about starting on antihypertensive medications. Which statement by the nurse would be an appropriate response? Select all that apply

A. “It is important that you monitor your blood pressure regularly and keep a record of it for follow up.” B. “While you are taking these medications it will be necessary for your healthcare provider to listen for bowel sounds.” C. “Your healthcare provider recommends that we review your diet history.” D. “The primary healthcare provider will have you come back for periodic laboratory checks to determine any changes in kidney function.” E. “It is recommended that you continue to engage in physical activity and maintain this over the course of a lifetime.”

Explanation

When teaching a patient about antihypertensive medications, the nurse should emphasize self-monitoring, lifestyle modifications, and regular follow-up assessments. These measures help determine the effectiveness of therapy, identify potential complications early (such as renal impairment or electrolyte imbalance), and promote long-term blood pressure control. Education and adherence are essential in preventing hypertension-related target organ damage.

Rationale for correct answers:

A. “It is important that you monitor your blood pressure regularly and keep a record of it for follow up.”
Regular blood pressure monitoring allows both the patient and healthcare provider to assess how well antihypertensive therapy is controlling hypertension. Keeping a written or electronic record helps track trends, evaluate medication effectiveness, and identify when dosage adjustments or additional therapies are needed.

C. “Your healthcare provider recommends that we review your diet history.”
Reviewing the diet history helps determine sodium, fat, and alcohol intake, all of which can influence blood pressure control. Diet modification—such as reducing sodium and following the DASH diet—is a key component of hypertension management and may reduce the need for higher medication doses.

D. “The primary healthcare provider will have you come back for periodic laboratory checks to determine any changes in kidney function.”
Many antihypertensive agents, especially ACE inhibitors, ARBs, and diuretics, can affect renal function and electrolyte balance. Periodic monitoring of serum creatinine and potassium levels ensures early detection of nephrotoxicity or hyperkalemia, allowing timely intervention.

E. “It is recommended that you continue to engage in physical activity and maintain this over the course of a lifetime.”
Regular physical activity improves cardiovascular health, enhances the effectiveness of antihypertensive medications, and supports weight management. Consistency over time is vital to sustain blood pressure control and reduce cardiovascular risk.

Rationales for incorrect answers:

B. “While you are taking these medications it will be necessary for your healthcare provider to listen for bowel sounds.”
Listening for bowel sounds is unrelated to antihypertensive therapy. This assessment is typically indicated for patients with gastrointestinal conditions or those receiving medications affecting bowel motility, not for hypertension management.

Take-home points:
• Consistent blood pressure monitoring and record-keeping help evaluate treatment effectiveness.
• Diet and kidney function monitoring are essential components of antihypertensive therapy.
• Regular physical activity and healthy lifestyle maintenance enhance medication effectiveness and long-term cardiovascular health.

Discussion Section

0 Pulse Checks

No comments

Practice Exercise 2

Question 4 :

A patient has developed mild hypertension. The nurse acknowledges that the first-line drug for treating this patient’s blood pressure might be which drug?

A. Diuretic B. Alpha blocker C. ACE inhibitor D. Alpha/beta blocker

Explanation

For a patient with mild hypertension, the first-line pharmacologic treatment is typically a thiazide diuretic. Diuretics help lower blood pressure by reducing extracellular fluid volume and decreasing peripheral vascular resistance, making them effective, safe, and cost-efficient for initial therapy.

Rationale for correct answer
A. Diuretic: Thiazide diuretics (e.g., hydrochlorothiazide, chlorthalidone) are recommended as first-line agents for mild to moderate hypertension. They enhance sodium and water excretion, reduce plasma volume, and lower cardiac output and blood pressure. They are especially beneficial in older adults and in combination with other antihypertensives when additional BP control is needed.

Rationale for incorrect answers
B. Alpha blocker: Drugs like prazosin lower BP by causing vasodilation but are not first-line because they can cause orthostatic hypotension and are less effective in reducing cardiovascular events.
C. ACE inhibitor: ACE inhibitors (e.g., lisinopril) are effective but are typically preferred in patients with specific comorbidities such as diabetes, heart failure, or chronic kidney disease rather than as first-line therapy for mild hypertension alone.
D. Alpha/beta blocker: Combined alpha and beta blockers (e.g., carvedilol) are generally reserved for patients with heart failure or post-myocardial infarction, not for initial treatment of mild hypertension.

Take-home points
• Thiazide diuretics remain the first-line drug for uncomplicated, mild hypertension.
• They are effective, inexpensive, and reduce cardiovascular morbidity and mortality.
• Combination therapy may be added if BP is not controlled with a diuretic alone.

Discussion Section

0 Pulse Checks

No comments

Question 5 :

The client has been given a prescription of furosemide (Lasix) as an adjunct to treatment of hypertension and returns for a follow-up check. Which of the following is the most objective data for determining the therapeutic effectiveness of the furosemide?

A. Absence of edema in lower extremities B. Weight loss of 6 lb C. Blood pressure log notes blood pressure 120/70 mmHg to 134/88 mmHg since discharge D. Frequency of voiding of at least six times per day

Explanation

Furosemide (Lasix) is a loop diuretic commonly prescribed as an adjunct therapy for hypertension and fluid overload. It acts by inhibiting sodium and water reabsorption in the loop of Henle, leading to increased urine output, decreased circulating volume, and ultimately lowered blood pressure. The most objective indicator of its therapeutic effectiveness in treating hypertension is a consistent reduction in blood pressure readings within the target range.

Rationale for correct answer:

C. Blood pressure log notes blood pressure 120/70 mmHg to 134/88 mmHg since discharge
The primary therapeutic goal of furosemide when used for hypertension is to lower and maintain blood pressure within normal limits. A log showing consistent readings between 120/70 and 134/88 mmHg demonstrates effective blood pressure control, confirming that the medication is achieving its desired therapeutic effect.

Rationales for incorrect answers:

A. Absence of edema in lower extremities
While the absence of edema suggests that furosemide’s diuretic effect is working, this finding reflects fluid balance improvement rather than direct control of hypertension. It supports but does not confirm therapeutic effectiveness for blood pressure management.

B. Weight loss of 6 lb
Weight loss likely indicates fluid loss due to diuresis, but it is an indirect measure. Fluid loss alone does not confirm blood pressure reduction, and weight can fluctuate due to several non-cardiac factors.

D. Frequency of voiding of at least six times per day
Increased urine output reflects the pharmacologic action of furosemide but not necessarily its therapeutic goal. Frequent urination indicates drug activity, not therapeutic success in reducing blood pressure.

Take-home points:
• The most objective measure of furosemide effectiveness in hypertension is consistent blood pressure reduction.
• Urine output and weight loss reflect drug activity but not necessarily blood pressure control.
• Nurses should emphasize regular BP monitoring and electrolyte balance in clients taking loop diuretics.

Discussion Section

0 Pulse Checks

No comments

Practice Exercise 3

Question 6 :

Captopril (Capoten) has been ordered for a patient. The nurse teaches the patient that angiotensin converting enzyme (ACE) inhibitors have which common side effects?

A. Nausea and vomiting B. Dizziness and headaches C. Upset stomach D. Constant, irritating cough

Explanation

Captopril (Capoten) is an angiotensin-converting enzyme (ACE) inhibitor used to treat hypertension, heart failure, and diabetic nephropathy. These drugs work by blocking the conversion of angiotensin I to angiotensin II, leading to vasodilation, decreased aldosterone secretion, and reduced blood pressure. One of the most common and characteristic side effects of ACE inhibitors is a persistent, dry, irritating cough, caused by the accumulation of bradykinin in the respiratory tract.

Rationale for correct answer:
D. Constant, irritating cough
ACE inhibitors prevent the breakdown of bradykinin and substance P, which are inflammatory mediators that can accumulate in the lungs, stimulating the cough reflex. This cough is nonproductive, persistent, and often described as tickling or irritating. It may develop within days to weeks after therapy begins and is more common in women and individuals of African descent.

Rationales for incorrect answers:
A. Nausea and vomiting
Although gastrointestinal upset can occur, nausea and vomiting are not common or characteristic side effects of ACE inhibitors. They may result from unrelated causes or excessive hypotension.

B. Dizziness and headaches
These symptoms can occur transiently at therapy initiation due to the vasodilatory effect and drop in blood pressure, but they are not considered hallmark side effects of ACE inhibitors. They usually resolve as the body adjusts to the medication.

C. Upset stomach
Mild gastrointestinal discomfort can happen but is nonspecific and less common compared to the dry cough. It is not unique to ACE inhibitors and can result from taking the medication on an empty stomach.

Take-home points:
• A persistent, dry, irritating cough is the most common side effect of ACE inhibitors like captopril.
• The cough results from bradykinin accumulation in the respiratory tract.
• If the cough becomes problematic, the drug may be replaced with an ARB such as losartan or valsartan.

Discussion Section

0 Pulse Checks

No comments

Question 7 :

The nurse is preparing to administer the first dose of enalapril (Vasotec). Identify the potential adverse effects of this medication. Select all that apply

A. Reflex hypertension B. Hyperkalemia C. Persistent cough D. Angioedema E. Hypotension

Explanation

Enalapril (Vasotec) is an angiotensin-converting enzyme (ACE) inhibitor used to treat hypertension and heart failure. It works by blocking the conversion of angiotensin I to angiotensin II, resulting in vasodilation, reduced aldosterone secretion, and decreased blood pressure. While effective, ACE inhibitors can cause several notable adverse effects such as hyperkalemia, persistent dry cough, angioedema, and hypotension, which require close monitoring and patient education.

Rationale for correct answers:
B. Hyperkalemia
By inhibiting aldosterone secretion, ACE inhibitors decrease potassium excretion in the kidneys, leading to elevated serum potassium levels. This can cause cardiac arrhythmias if left unchecked, making potassium monitoring essential during therapy.

C. Persistent cough
ACE inhibitors cause accumulation of bradykinin in the lungs, resulting in a dry, irritating cough that does not respond to cough suppressants. This is a common and often dose-limiting side effect that may require a switch to an ARB (angiotensin II receptor blocker).

D. Angioedema
A potentially life-threatening allergic reaction, angioedema presents as swelling of the face, lips, tongue, and airway. It results from increased bradykinin levels and requires immediate medical attention to prevent airway obstruction.

E. Hypotension
Enalapril lowers blood pressure by reducing vascular resistance and preload, which can cause first-dose hypotension, particularly in clients who are volume-depleted or on diuretics. Nurses should monitor blood pressure closely after the initial dose.

Rationale for incorrect answer:

A. Reflex hypertension
Reflex hypertension is not associated with ACE inhibitors. Instead, enalapril lowers blood pressure. Reflex tachycardia may occur with vasodilators such as hydralazine or nitrates, but not with ACE inhibitors, which typically slow the heart rate slightly.

Take-home points:

ACE inhibitors can cause hyperkalemia, cough, angioedema, and hypotension; all require close monitoring.
The persistent dry cough results from bradykinin accumulation and may necessitate discontinuation.
Angioedema is a medical emergency; patients should seek immediate help if facial or throat swelling occurs.

Discussion Section

0 Pulse Checks

No comments

Question 8 :

A nurse is caring for a client who is starting captopril (Capoten) for hypertension. For which of the following adverse effects should the nurse monitor the client?

A. Hypokalemia B. Hypernatremia C. Neutropenia D. Anemia

Explanation

Captopril (Capoten) is an angiotensin-converting enzyme (ACE) inhibitor used to treat hypertension, heart failure, and diabetic nephropathy. It works by blocking the conversion of angiotensin I to angiotensin II, leading to vasodilation, decreased aldosterone secretion, and reduced blood pressure. One of its rare but serious adverse effects is neutropenia, a condition characterized by an abnormally low number of neutrophils, which increases the risk of infection.

Rationale for correct answer:
C. Neutropenia
ACE inhibitors such as captopril can cause bone marrow suppression, leading to neutropenia or agranulocytosis, especially in clients with renal impairment or autoimmune disorders. The nurse should monitor the white blood cell count and report signs of infection such as fever, sore throat, or fatigue. Early detection is crucial, as untreated neutropenia can lead to severe infection and sepsis.

Rationales for incorrect answers:
A. Hypokalemia
Captopril tends to cause hyperkalemia, not hypokalemia, because decreased aldosterone secretion reduces potassium excretion by the kidneys. Potassium levels should be monitored, but hypokalemia is not expected.

B. Hypernatremia
ACE inhibitors promote sodium and water excretion, which helps lower blood pressure. Therefore, hyponatremia, not hypernatremia, may occur.

D. Anemia
While mild anemia can occasionally occur, it is not a typical or major adverse effect of captopril. The nurse’s priority should be monitoring for neutropenia and hyperkalemia.

Take-home points:

Captopril can cause neutropenia; monitor white blood cell count and report infection signs promptly.
ACE inhibitors decrease aldosterone, leading to possible hyperkalemia and hyponatremia.
Regular blood tests are essential during captopril therapy to detect hematologic complications early.

Discussion Section

0 Pulse Checks

No comments

Practice Exercise 4

Question 9 :

A patient is prescribed losartan (Cozaar). The nurse teaches the patient that an angiotensin II receptor blocker (ARB) acts by doing what?

A. Inhibiting angiotensin-converting enzyme B. Blocking angiotensin II from AT1 receptors C. Preventing the release of angiotensin I D. Promoting the release of aldosterone

Explanation

Losartan (Cozaar) is an angiotensin II receptor blocker (ARB) used in the treatment of hypertension, heart failure, and diabetic nephropathy. ARBs act by blocking the binding of angiotensin II to the angiotensin II type 1 (AT₁) receptors on vascular smooth muscle and the adrenal glands. This action results in vasodilation, reduced secretion of aldosterone, and ultimately lower blood pressure. Unlike ACE inhibitors, ARBs do not increase bradykinin levels, which means they are less likely to cause a persistent dry cough.

Rationale for correct answer:
B. Blocking angiotensin II from AT1 receptors
ARBs such as losartan work by selectively blocking angiotensin II from binding to AT₁ receptors located in the vascular smooth muscle, heart, and adrenal cortex. This prevents the vasoconstrictive and sodium-retaining effects of angiotensin II. Consequently, blood vessels relax, aldosterone secretion decreases, and sodium and water excretion are enhanced.

Rationales for incorrect answers:
A. Inhibiting angiotensin-converting enzyme
This describes the action of ACE inhibitors (e.g., captopril, lisinopril), not ARBs. ACE inhibitors block the conversion of angiotensin I to angiotensin II, while ARBs act further down the pathway by blocking angiotensin II’s receptor sites.

C. Preventing the release of angiotensin I
No antihypertensive class directly prevents the release of angiotensin I. Angiotensin I formation depends on renin activity, which ARBs do not inhibit. Instead, ARBs specifically block the effect of angiotensin II at the receptor level.

D. Promoting the release of aldosterone
ARBs actually inhibit aldosterone secretion, which leads to increased sodium and water excretion and potassium retention. Promoting aldosterone release would worsen hypertension, not treat it.

Take-home points:
• ARBs block angiotensin II from binding to AT₁ receptors, leading to vasodilation and decreased aldosterone secretion.
• Unlike ACE inhibitors, ARBs do not affect bradykinin, making them less likely to cause a dry cough.
• ARBs effectively reduce blood pressure and improve cardiac workload without altering angiotensin II production.

Discussion Section

0 Pulse Checks

No comments

Question 10 :

The nurse preparing the drug irbesartan (Avapro) from the drug class angiotensin II receptor blockers knows that this drug works by which mechanism?

A. Inhibiting the conversion of angiotensin I to angiotensin II B. Binding to and blocking angiotensin II receptor sites C. Preventing the release of catecholamines D. Blocking the stimulation of mineralocorticoid receptors

Explanation

Irbesartan (Avapro) is an angiotensin II receptor blocker (ARB) used to manage hypertension and diabetic nephropathy. ARBs work by blocking the binding of angiotensin II to its receptor sites on vascular smooth muscle and adrenal tissue. This action causes vasodilation, reduced aldosterone secretion, and decreased blood pressure without affecting bradykinin metabolism—leading to fewer side effects such as cough compared to ACE inhibitors.

Rationale for correct answer:
B. Binding to and blocking angiotensin II receptor sites
Irbesartan selectively blocks angiotensin II from binding to AT₁ receptors in vascular smooth muscle and the adrenal gland. By preventing this binding, it inhibits vasoconstriction and aldosterone secretion, leading to decreased sodium and water retention and a subsequent reduction in blood pressure.

Rationales for incorrect answers:
A. Inhibiting the conversion of angiotensin I to angiotensin II
This describes the mechanism of ACE inhibitors, not ARBs. ACE inhibitors block the angiotensin-converting enzyme, preventing formation of angiotensin II, while ARBs act further downstream at the receptor level.

C. Preventing the release of catecholamines
This mechanism relates to adrenergic blockers (e.g., beta-blockers), which reduce sympathetic nervous system activity. ARBs do not influence catecholamine release or adrenergic receptor activity.

D. Blocking the stimulation of mineralocorticoid receptors
This action pertains to aldosterone antagonists (e.g., spironolactone, eplerenone), which block aldosterone at the receptor level in the kidneys. ARBs indirectly reduce aldosterone secretion but do not directly block its receptors.

Take-home points:

ARBs like irbesartan block angiotensin II receptors, preventing vasoconstriction and aldosterone release.
They lower blood pressure by promoting vasodilation and reducing sodium and water retention.
Unlike ACE inhibitors, ARBs do not cause cough or angioedema because they do not affect bradykinin levels.

Discussion Section

0 Pulse Checks

No comments

Practice Exercise 5

Question 11 :

During an admission assessment, a patient states that she takes amlodipine (Norvasc). The nurse wishes to determine whether the patient has any common side effects of a calcium channel blocker. The nurse asks the patient if she has which signs and symptoms? Select all that apply

A. Insomnia B. Dizziness C. Headache D. Angioedema E. Ankle edema F. Hacking cough

Explanation

Amlodipine (Norvasc) is a calcium channel blocker (CCB) used to treat hypertension and angina by causing vasodilation and reduced myocardial workload. Because of its vasodilatory effect, patients often experience dizziness, headache, and ankle edema as common side effects. Recognizing these symptoms helps the nurse assess drug tolerance and effectiveness while differentiating CCB-related effects from adverse reactions seen in other antihypertensive classes such as ACE inhibitors.

Rationale for correct answer:

B. Dizziness
Amlodipine induces vasodilation, leading to lowered blood pressure, which can cause transient dizziness or lightheadedness, especially when changing positions. The nurse should educate the patient to rise slowly to prevent falls related to postural hypotension.

C. Headache
Vasodilation of cerebral vessels commonly triggers headaches, particularly during initial therapy. These headaches are typically mild and may diminish as the body adjusts to the medication.

E. Ankle edema
Peripheral (ankle) edema results from increased capillary hydrostatic pressure due to arterial dilation, leading to fluid leakage into interstitial tissues. It is one of the most frequent side effects of calcium channel blockers and often dose-related.

Rationales for incorrect answers:

A. Insomnia
Amlodipine does not stimulate the central nervous system and rarely causes sleep disturbances. Insomnia is not considered a typical or expected side effect.

D. Angioedema
Angioedema is associated with ACE inhibitors (e.g., lisinopril), not calcium channel blockers. Amlodipine does not affect bradykinin metabolism, the mechanism responsible for angioedema in ACE inhibitor use.

F. Hacking cough
A persistent, dry cough is another hallmark side effect of ACE inhibitors, not CCBs. Since amlodipine does not increase bradykinin levels, this symptom would not be expected.

Take-home points:
• Common side effects of amlodipine include dizziness, headache, and ankle edema due to vasodilation.
• Angioedema and cough are characteristic of ACE inhibitors, not calcium channel blockers.
• Educate patients to change positions slowly and monitor for ankle swelling during therapy.

Discussion Section

0 Pulse Checks

No comments

Question 12 :

Nifedipine (Procardia) has been ordered for a client with hypertension. In the care plan, the nurse includes the need to monitor for which adverse effect?

A. Rash and chills B. Reflex tachycardia C. Increased urinary output D. Weight loss

Explanation

Nifedipine (Procardia) is a calcium channel blocker (CCB) that works by inhibiting calcium influx into vascular smooth muscle, causing arterial vasodilation and reduced systemic vascular resistance, which helps lower blood pressure. However, the sudden vasodilation can trigger the baroreceptor reflex, leading to reflex tachycardia—a compensatory increase in heart rate as the body attempts to maintain cardiac output.

Rationale for correct answer:

B. Reflex tachycardia
When nifedipine causes rapid vasodilation, systemic blood pressure drops suddenly, and the body compensates by stimulating the sympathetic nervous system, resulting in reflex tachycardia. This increased heart rate can increase myocardial oxygen demand, which may be harmful, especially in clients with coronary artery disease or angina.

Rationales for incorrect answers:

A. Rash and chills
These are not typical side effects of nifedipine. Rash and chills would more likely suggest hypersensitivity or infection, which are unrelated to the drug’s mechanism of action.

C. Increased urinary output
Unlike diuretics, nifedipine does not directly affect the kidneys or promote diuresis. Its antihypertensive effect occurs through vascular smooth muscle relaxation, not fluid excretion.

D. Weight loss
Weight loss is not associated with nifedipine therapy. While some antihypertensive drugs indirectly influence body weight (e.g., diuretics through fluid loss), nifedipine has no such effect.

Take-home points:
• Reflex tachycardia is a key adverse effect of nifedipine due to sudden vasodilation.
• The nurse should monitor heart rate and report chest pain or palpitations promptly.
• Nifedipine does not cause diuresis or weight loss, distinguishing it from diuretic antihypertensives.

Discussion Section

0 Pulse Checks

No comments

Question 13 :

A nurse is teaching a client who is starting verapamil (Calan) to control hypertension. Which of the following should the nurse include in the teaching?

A. Increase the amount of dietary fiber in the diet. B. Drink grapefruit juice daily to increase vitamin C intake. C. Decrease the amount of calcium in the diet. D. Withhold food for 1 hr after the medication is taken.

Explanation

Verapamil (Calan) is a calcium channel blocker used to treat hypertension, angina, and certain cardiac dysrhythmias. It works by blocking calcium influx into vascular smooth muscle and myocardial cells, leading to vasodilation, decreased heart rate, and reduced myocardial contractility. However, verapamil is known to slow intestinal motility, which commonly results in constipation. Therefore, increasing dietary fiber and fluids helps prevent this adverse effect.

Rationale for correct answer:
A. Increase the amount of dietary fiber in the diet.
Constipation is one of the most common side effects of verapamil due to reduced smooth muscle contractility in the gastrointestinal tract. The nurse should instruct the client to increase fiber intake (e.g., fruits, vegetables, whole grains), maintain adequate hydration, and stay physically active to minimize this effect.

Rationales for incorrect answers:
B. Drink grapefruit juice daily to increase vitamin C intake.
Grapefruit juice inhibits cytochrome P450 enzymes, which can increase plasma levels of verapamil, leading to toxicity, hypotension, and bradycardia. The client should be advised to avoid grapefruit juice while taking this medication.

C. Decrease the amount of calcium in the diet.
Dietary calcium intake does not interfere with the action or effectiveness of calcium channel blockers. There is no need to restrict calcium-containing foods.

D. Withhold food for 1 hr after the medication is taken.
Verapamil can be taken with or without food, but taking it with meals may help reduce gastric irritation. There is no requirement to delay eating after taking the medication.

Take-home points:

Constipation is a common side effect of verapamil; clients should increase dietary fiber and fluid intake.
Avoid grapefruit juice when taking verapamil to prevent drug toxicity.
Calcium channel blockers can be taken with meals and do not require dietary calcium restriction.

Discussion Section

0 Pulse Checks

No comments

Practice Exercise 6

Question 14 :

The nurse is administering a beta blocker to a patient. Which is an important assessment to perform before administration?

A. Urine output B. Apical pulse C. Potassium level D. Serum level of medication

Explanation

Before administering a beta blocker, it is essential for the nurse to assess the client’s apical pulse because beta blockers act by blocking beta-adrenergic receptors in the heart, which reduce heart rate, myocardial contractility, and cardiac output. Monitoring the apical pulse helps prevent complications such as bradycardia and hypotension, which are common adverse effects of these medications. This assessment ensures that the drug is safe to give and guides appropriate clinical decision-making.

Rationale for correct answer:
B. Apical pulse
Beta blockers (e.g., metoprolol, atenolol, propranolol) slow the heart rate by inhibiting sympathetic stimulation. The nurse must measure the apical pulse for a full minute before administration. If the pulse is below 50–60 beats per minute (depending on facility policy), the medication should be withheld and the healthcare provider notified. Assessing the apical pulse allows the nurse to detect bradycardia early and prevent potential cardiac complications such as heart block or symptomatic hypotension.

Rationales for incorrect answers:
A. Urine output
Although important for overall fluid balance assessment, urine output is not directly affected by beta blockers. This assessment is more relevant for diuretics or drugs that influence renal perfusion.

C. Potassium level
Potassium monitoring is essential for clients taking diuretics, ACE inhibitors, or ARBs, but beta blockers do not significantly alter potassium levels in most patients. Therefore, it is not a priority assessment before administering this medication.

D. Serum level of medication
Beta blockers are not routinely monitored through serum drug levels, as their effects are assessed clinically through heart rate and blood pressure measurements. Drug levels are typically measured for medications with narrow therapeutic ranges such as digoxin or lithium.

Take-home points:
• Always check the apical pulse for one full minute before administering a beta blocker.
• Hold the medication and notify the provider if the pulse is below 50–60 bpm or the client shows signs of bradycardia.
• Beta blockers primarily affect heart rate and contractility, making cardiac monitoring a top nursing priority.

Discussion Section

0 Pulse Checks

No comments

Practice Exercise 7

Question 15 :

A nurse in an acute care facility is infusing IV nitroprusside for a client who is in hypertensive crisis. For which of the following adverse reactions should the nurse monitor this client?

A. Intestinal ileus B. Neutropenia C. Delirium D. Hyperthermia

Explanation

Nitroprusside is a direct-acting vasodilator used for rapid reduction of blood pressure during hypertensive crisis. It acts by relaxing vascular smooth muscle, causing both arterial and venous dilation, which decreases afterload and preload. However, prolonged or high-dose infusions can lead to cyanide or thiocyanate toxicity, particularly in clients with renal impairment. One of the early and significant signs of this toxicity is delirium or other changes in mental status.

Rationale for correct answer:
C. Delirium
When nitroprusside is metabolized, it releases cyanide ions, which are then converted to thiocyanate by the liver. Accumulation of these metabolites—especially during prolonged infusions or in renal dysfunction—can cause central nervous system toxicity, manifesting as delirium, disorientation, psychosis, or seizures. The nurse should monitor the client’s neurological status, serum thiocyanate levels, and ensure the infusion rate does not exceed recommended limits.

Rationales for incorrect answers:
A. Intestinal ileus
Nitroprusside does not directly affect gastrointestinal motility. Ileus is unrelated to its mechanism of action or toxicity profile.

B. Neutropenia
Neutropenia is not an adverse effect associated with nitroprusside therapy. This hematologic reaction is more commonly linked with drugs such as captopril or chemotherapeutic agents.

D. Hyperthermia
Hyperthermia is not a known adverse reaction to nitroprusside. Instead, metabolic acidosis, hypotension, and altered mental status are signs of toxicity.

Take-home points:

Delirium and confusion are early indicators of thiocyanate toxicity from nitroprusside.
Prolonged infusions and renal impairment increase the risk of cyanide accumulation.
Continuous blood pressure and neurological monitoring are essential during nitroprusside therapy.

Discussion Section

0 Pulse Checks

No comments

Comprehensive Questions

Question 16 :

An African-American patient has developed hypertension. The nurse is aware that which group(s) of antihypertensive drugs are less effective in African-American patients?

A. Diuretics B. Calcium channel blockers and vasodilators C. Beta blockers and ACE inhibitors D. Alpha blockers

Explanation

Hypertension in African-American patients tends to respond differently to various antihypertensive drug classes due to genetic and physiological variations in the renin-angiotensin system and salt sensitivity. Studies show that Beta blockers and ACE inhibitors are less effective as monotherapy in African-American patients because they have a low-renin profile. These clients respond better to calcium channel blockers and thiazide diuretics, which act independently of renin levels to control blood pressure effectively.

Rationale for correct answer:
C. Beta blockers and ACE inhibitors
African-American patients often exhibit low plasma renin activity, meaning they produce less renin and therefore less angiotensin II. Since ACE inhibitors work by blocking the conversion of angiotensin I to angiotensin II, and beta blockers reduce renin release from the kidneys, these drugs have diminished antihypertensive effects in this population when used alone. However, when combined with diuretics, their effectiveness improves.

Rationales for incorrect answers:
A. Diuretics
Thiazide diuretics are highly effective in African-American patients. They promote sodium and water excretion, which directly reduces blood pressure without depending on renin levels. They are often part of the first-line therapy for hypertension in this population.

B. Calcium channel blockers and vasodilators
Calcium channel blockers are particularly effective in African-American patients because they cause vasodilation through inhibition of calcium influx into vascular smooth muscle, leading to improved blood pressure control. Vasodilators can also be effective in resistant hypertension.

D. Alpha blockers
Alpha blockers, such as prazosin, lower blood pressure by relaxing vascular smooth muscles and have no evidence of reduced efficacy in African-American patients. However, they are usually not first-line agents due to risks of orthostatic hypotension and reflex tachycardia.

Take-home points:
• Beta blockers and ACE inhibitors are less effective as monotherapy in African-American patients due to low renin levels.
• Thiazide diuretics and calcium channel blockers are preferred for initial hypertension management in this population.
• Combination therapy with a diuretic can improve the effectiveness of ACE inhibitors and beta blockers.

Discussion Section

0 Pulse Checks

No comments

Question 17 :

The nurse knows that which diuretic is most frequently combined with an antihypertensive drug?

A. chlorthalidone B. hydrochlorothiazide C. bendroflumethiazide D. potassium-sparing diuretic

Explanation

Hydrochlorothiazide (HCTZ) is the most frequently combined diuretic with various antihypertensive agents such as ACE inhibitors, ARBs, beta blockers, and calcium channel blockers. This is because it has a proven ability to enhance blood pressure control, works synergistically with other antihypertensives, and has a long record of safety and efficacy. By reducing plasma volume and peripheral resistance, hydrochlorothiazide helps improve blood pressure outcomes while allowing for lower doses of other drugs, minimizing side effects.

Rationale for correct answer:
B. Hydrochlorothiazide
Hydrochlorothiazide is a thiazide diuretic that acts on the distal convoluted tubule to inhibit sodium and water reabsorption, promoting mild diuresis and reducing blood pressure. It is commonly combined with antihypertensive agents like ACE inhibitors or ARBs (e.g., lisinopril/HCTZ or losartan/HCTZ) to enhance efficacy, especially in populations such as African-American clients, where thiazides show superior response.

Rationales for incorrect answers:
A. Chlorthalidone
Although chlorthalidone is also a thiazide-like diuretic and may be more potent than HCTZ, it is less frequently used in fixed-dose combination products. It has a longer half-life, but HCTZ remains the most common diuretic found in combination formulations due to extensive clinical use and established safety data.

C. Bendroflumethiazide
This diuretic is used in some regions (especially the UK), but it is not as widely available or commonly combined with antihypertensive agents as hydrochlorothiazide in standard practice, particularly in the United States.

D. Potassium-sparing diuretic
Agents such as spironolactone or amiloride are sometimes combined with thiazides to reduce potassium loss, but they are not the most frequent diuretic combined with antihypertensives. These are typically used in resistant hypertension or in patients with specific conditions like heart failure.

Take-home points:
• Hydrochlorothiazide is the most commonly combined diuretic with antihypertensive drugs due to its proven efficacy and safety.
• Thiazide diuretics lower blood pressure by reducing plasma volume and peripheral vascular resistance.
• Combining hydrochlorothiazide with ACE inhibitors or ARBs enhances blood pressure control and reduces adverse effects like hypokalemia.

Discussion Section

0 Pulse Checks

No comments

Question 18 :

The client is taking atenolol (Tenormin) and doxazosin (Cardura). What is the rationale for combining two antihypertensive drugs?

A. The blood pressure will decrease faster. B. Lower doses of both drugs may be given with fewer adverse effects. C. There is less daily medication dosing. D. Combination therapy will treat the patient’s other medical conditions.

Explanation

Atenolol (Tenormin) is a beta-adrenergic blocker that decreases heart rate, cardiac output, and renin release, while doxazosin (Cardura) is an alpha-adrenergic blocker that causes vasodilation by relaxing vascular smooth muscle. Combining these two antihypertensive agents targets different mechanisms involved in blood pressure regulation, allowing for synergistic blood pressure reduction while minimizing side effects associated with higher doses of a single medication.

Rationale for correct answer:

B. Lower doses of both drugs may be given with fewer adverse effects.
Combination therapy allows each drug to complement the other’s mechanism of action—atenolol reduces cardiac workload and renin secretion, while doxazosin reduces peripheral vascular resistance. This dual approach enables the use of lower doses of both drugs, enhancing efficacy and reducing the risk of dose-related adverse effects such as bradycardia (from beta blockers) or postural hypotension (from alpha blockers).

Rationales for incorrect answers:

A. The blood pressure will decrease faster.
The goal of combination therapy is safe and sustained blood pressure control, not a rapid decrease. A sudden drop in BP can lead to hypotension, dizziness, or syncope, especially in older adults.

C. There is less daily medication dosing.
Combination therapy often involves multiple doses or separate tablets, not necessarily fewer doses. The purpose is enhanced control, not dosing convenience.

D. Combination therapy will treat the patient’s other medical conditions.
Although atenolol may help with cardiac conditions like angina, combination therapy in this context is specifically aimed at improving blood pressure control, not managing unrelated diseases.

Take-home points:
• Combining antihypertensive drugs with different mechanisms enhances blood pressure control and limits side effects.
• Lower doses of each drug in combination therapy improve tolerability and adherence.
• The goal is balanced, sustained blood pressure reduction, not rapid or multi-condition treatment.

Discussion Section

0 Pulse Checks

No comments

Question 19 :

What health teaching should the nurse provide for the client receiving nadolol (Corgard)?

A. Increase fluids and fiber to prevent constipation. B. Report a weight gain of 1 kg per month or more. C. Immediately stop taking the medication if sexual dysfunction occurs. D. Rise slowly after prolonged periods of sitting or lying down.

Explanation

Nadolol (Corgard) is a nonselective beta-adrenergic blocker used in the management of hypertension and angina pectoris. It decreases heart rate, myocardial contractility, and cardiac output, thereby lowering blood pressure. One of its common adverse effects is orthostatic hypotension, which can cause dizziness or fainting when changing positions quickly. Therefore, clients must be educated on safety measures to prevent falls and injuries related to this side effect.

Rationale for correct answer:
D. Rise slowly after prolonged periods of sitting or lying down.
Nadolol can cause postural (orthostatic) hypotension due to its blood pressure–lowering effects. Clients may feel dizzy, lightheaded, or faint when standing up suddenly. Teaching the client to rise slowly allows the body time to adjust to the change in position, preventing dizziness and falls.

Rationales for incorrect answers:

A. Increase fluids and fiber to prevent constipation.
Constipation is not a typical adverse effect of nadolol. Increasing fiber and fluids is more applicable to drugs such as opioids or calcium channel blockers, not beta blockers.

B. Report a weight gain of 1 kg per month or more.
Although weight gain can be concerning in clients with heart failure, the nurse should teach the client to report rapid weight gain (e.g., 1–2 kg in 2 days), not gradual monthly gain. Nadolol’s main concern is bradycardia and hypotension, not fluid retention.

C. Immediately stop taking the medication if sexual dysfunction occurs.
Abruptly discontinuing nadolol can lead to rebound hypertension or angina, which may precipitate a myocardial infarction. The client should report sexual dysfunction to the provider, not stop the drug independently.

Take-home points:

Nadolol can cause orthostatic hypotension; clients should rise slowly to prevent dizziness and falls.
Never stop beta blockers abruptly; doing so can trigger rebound hypertension or angina.
Client education focuses on safety, adherence, and recognizing symptoms requiring provider notification.

Discussion Section

0 Pulse Checks

No comments

Question 20 :

A client with significant hypertension unresponsive to other medications is given a prescription for hydralazine (Apresoline). An additional prescription of propranolol (Inderal) is also given to the client. The client inquires why two drugs are needed. What is the nurse’s best response?

A. Giving the two drugs together will lower the blood pressure even more than just one alone. B. The hydralazine may cause tachycardia and the propranolol will help keep the heart rate within normal limits. C. The propranolol is to prevent lupus erythematosus from developing. D. Direct-acting vasodilators such as hydralazine cause fluid retention and the propranolol will prevent excessive fluid buildup.

Explanation

Hydralazine (Apresoline) is a direct-acting vasodilator that relaxes the smooth muscles of arterioles, leading to reduced peripheral resistance and decreased blood pressure. However, this sudden vasodilation can trigger a reflex sympathetic response, causing tachycardia and increased cardiac output. To counteract this compensatory effect, a beta blocker such as propranolol (Inderal) is prescribed concurrently to maintain a stable heart rate and prevent excessive cardiac workload.

Rationale for correct answer:
B. The hydralazine may cause tachycardia and the propranolol will help keep the heart rate within normal limits.
Hydralazine’s vasodilatory effect decreases systemic vascular resistance, prompting a reflex increase in heart rate and contractility. Propranolol, a nonselective beta-adrenergic blocker, inhibits sympathetic stimulation, thereby reducing heart rate, myocardial oxygen demand, and cardiac workload.

Rationales for incorrect answers:

A. Giving the two drugs together will lower the blood pressure even more than just one alone.
While combination therapy can enhance blood pressure control, the main reason for adding propranolol is not simply to intensify the hypotensive effect, but to prevent reflex tachycardia and excessive cardiac stimulation caused by hydralazine.

C. The propranolol is to prevent lupus erythematosus from developing.
Drug-induced lupus-like syndrome is a rare side effect of hydralazine, but propranolol does not prevent this condition. Monitoring for symptoms such as joint pain, rash, and fever is more appropriate than using propranolol for prevention.

D. Direct-acting vasodilators such as hydralazine cause fluid retention and the propranolol will prevent excessive fluid buildup.
Fluid retention occurs due to activation of the renin-angiotensin system after vasodilation. Diuretics, not beta blockers, are used to counteract this effect. Propranolol helps control heart rate, not fluid balance.

Take-home points:

Hydralazine causes reflex tachycardia; propranolol is added to prevent an excessive heart rate.
Beta blockers reduce sympathetic stimulation and cardiac workload when used with vasodilators.
Combination therapy in hypertension aims to improve control while minimizing drug-induced side effects.

Discussion Section

0 Pulse Checks

No comments

Question 21 :

A nurse is reviewing the health record of a client who is starting propranolol (Inderal) to treat hypertension. Which of the following conditions is a contraindication for taking propranolol?

A. Asthma B. Diabetes C. Angina D. Tachycardia

Explanation

Propranolol (Inderal) is a non-selective beta-adrenergic blocker used to manage hypertension, angina, and arrhythmias. It works by blocking both beta-1 and beta-2 receptors, which reduces heart rate and cardiac output. However, blocking beta-2 receptors in the lungs causes bronchoconstriction, making this drug contraindicated in clients with asthma or other obstructive pulmonary diseases.

Rationale for correct answer:
A. Asthma
Propranolol blocks beta-2 receptors in bronchial smooth muscle, leading to bronchospasm and airway constriction, which can precipitate a life-threatening asthma attack. For clients with asthma or COPD, a cardioselective beta-blocker (like metoprolol or atenolol) is preferred, as these primarily target beta-1 receptors in the heart with less effect on the lungs.

Rationales for incorrect answers:
B. Diabetes
Although propranolol can mask symptoms of hypoglycemia such as tachycardia, it is not an absolute contraindication. Caution is needed, and diabetic clients should monitor their blood glucose closely.

C. Angina
Propranolol is commonly prescribed to treat angina pectoris because it reduces myocardial oxygen demand by lowering heart rate and contractility. It is not contraindicated for this condition.

D. Tachycardia
Propranolol is often used to control tachycardia, especially those related to anxiety or hyperthyroidism, by decreasing sympathetic stimulation of the heart. It is therefore therapeutic, not contraindicated.

Take-home points:

Propranolol is contraindicated in clients with asthma due to the risk of bronchospasm.
Non-selective beta-blockers affect both the heart and lungs, whereas cardioselective ones primarily target the heart.
Clients with diabetes taking propranolol require careful glucose monitoring because symptoms of hypoglycemia can be masked.

Discussion Section

0 Pulse Checks

No comments

Question 22 :

A nurse is planning to administer a first dose of captopril (Capoten) to a hospitalized client who has hypertension. Which of the following medications can intensify early adverse effects of captopril? Select all that apply

A. Simvastatin (Zocor) B. Hydrochlorothiazide (HydroDIURIL) C. Phenytoin (Dilantin) D. Clonidine (Catapres) E. Aliskiren (Tekturna)

Explanation

Captopril (Capoten) is an angiotensin-converting enzyme (ACE) inhibitor used to manage hypertension and heart failure. It lowers blood pressure by blocking the conversion of angiotensin I to angiotensin II, leading to vasodilation and decreased fluid retention. However, certain medications can intensify captopril’s early adverse effects, such as first-dose hypotension, hyperkalemia, and renal impairment, especially when given concurrently.

Rationale for correct answers:

B. Hydrochlorothiazide (HydroDIURIL):
Hydrochlorothiazide is a thiazide diuretic that promotes sodium and water excretion, leading to volume depletion. When administered with captopril, the risk of first-dose hypotension significantly increases due to reduced circulating volume and enhanced vasodilatory effects of the ACE inhibitor. The nurse should monitor blood pressure closely after the first dose.

D. Clonidine (Catapres):
Clonidine is a centrally acting alpha-2 adrenergic agonist that decreases sympathetic outflow, lowering blood pressure. When combined with captopril, there is an additive hypotensive effect, which can lead to excessive dizziness, syncope, or orthostatic hypotension, especially after the first dose.

E. Aliskiren (Tekturna):
Aliskiren is a direct renin inhibitor that suppresses the renin-angiotensin-aldosterone system (RAAS) at an earlier step than ACE inhibitors. Combining it with captopril can lead to severe hypotension, hyperkalemia, and renal dysfunction due to synergistic RAAS inhibition. The combination is generally contraindicated in clients with diabetes or renal impairment.

Rationales for incorrect answers:

A. Simvastatin (Zocor):
Simvastatin is a HMG-CoA reductase inhibitor (statin) used to lower cholesterol. It has no significant pharmacologic interaction with captopril and does not intensify its adverse effects.

C. Phenytoin (Dilantin):
Phenytoin is an anticonvulsant used to prevent seizures. It does not act on the cardiovascular system in a way that interacts with ACE inhibitors, nor does it potentiate hypotensive or electrolyte-related side effects.

Take-home points:
• Captopril’s first-dose hypotension is worsened by other antihypertensives or diuretics.
• Concurrent RAAS inhibitors like aliskiren increase the risk of hyperkalemia and renal dysfunction.
• Nurses should monitor blood pressure and renal function closely when captopril is used with other antihypertensives.

Discussion Section

0 Pulse Checks

No comments

Question 23 :

The nurse is administering antihypertensive drugs to older adult patients. The nurse knows that which adverse effect is of most concern for these patients?

A. Dry mouth B. Hypotension C. Restlessness D. Constipation

Explanation

Older adults taking antihypertensive medications are at increased risk for hypotension, particularly orthostatic (postural) hypotension, due to age-related physiological changes and altered drug metabolism. These changes make them more sensitive to blood pressure–lowering effects, which can lead to dangerous complications such as falls, syncope, and injury.

Rationale for correct answer:

B. Hypotension:
Hypotension, especially orthostatic hypotension, is the most concerning adverse effect in older adults receiving antihypertensive therapy. Aging reduces baroreceptor sensitivity, making it harder for the cardiovascular system to compensate for sudden position changes. This increases the risk of dizziness, fainting, and falls, which can result in fractures or head injuries. Nurses should monitor blood pressure regularly, particularly when clients move from lying to standing, and educate them to rise slowly.

Rationales for incorrect answers:

A. Dry mouth:
Although dry mouth can occur with some antihypertensive agents (e.g., clonidine), it is a minor discomfort compared to the safety risks associated with hypotension. It can be managed with oral fluids, sugar-free gum, or saliva substitutes.

C. Restlessness:
Restlessness is not a typical adverse effect of most antihypertensive medications. It may occur from anxiety or unrelated causes but is not the main concern in this population.

D. Constipation:
Constipation can occur with certain antihypertensives (e.g., verapamil), but it is not life-threatening and is manageable with dietary adjustments or stool softeners. It poses far less danger than hypotension and fall-related injuries.

Take-home points:
• Hypotension and orthostatic hypotension are the most serious risks of antihypertensive therapy in older adults.
• Falls and injuries are common complications due to impaired cardiovascular reflexes.
• Nurses should monitor blood pressure closely and instruct patients to change positions slowly to prevent dizziness and fainting.

Discussion Section

0 Pulse Checks

No comments

Question 24 :

When giving antihypertensive drugs, the nurse will consider giving the first dose at bedtime for which class of drugs?

A. Alpha blockers such as doxazosin (Cardura) B. Diuretics such as furosemide (Lasix) C. ACE inhibitors such as captopril (Capoten) D. Vasodilators such as hydralazine (Apresoline)

Explanation

Alpha blockers such as doxazosin (Cardura) are known to cause a pronounced first-dose orthostatic hypotensive effect, especially after the initial administration. This sudden drop in blood pressure can result in dizziness, syncope, or fainting, particularly when moving from lying to standing. Administering the first dose at bedtime helps minimize the risk of injury from falls or fainting episodes during this adjustment period.

Rationale for correct answer:

A. Alpha blockers such as doxazosin (Cardura):
Alpha-adrenergic blockers work by causing vasodilation through the relaxation of smooth muscle in blood vessels, leading to a decrease in peripheral vascular resistance. However, the initial dose can cause a marked drop in blood pressure, known as the “first-dose phenomenon.” Giving the first dose at bedtime helps reduce the client’s risk of falling or fainting, as they are in a supine position when the drug takes effect.

Rationales for incorrect answers:

B. Diuretics such as furosemide (Lasix):
Diuretics increase urine output, which can lead to nocturia if taken at bedtime. Therefore, they are typically administered in the morning to prevent nighttime interruptions and maintain patient safety.

C. ACE inhibitors such as captopril (Capoten):
Although ACE inhibitors can cause hypotension, especially after the first dose, the effect is generally less abrupt than that seen with alpha blockers. Timing of administration is flexible and not specifically recommended at bedtime unless the client experiences dizziness.

D. Vasodilators such as hydralazine (Apresoline):
Vasodilators may cause hypotension, but the first-dose phenomenon is not as pronounced as with alpha blockers. These drugs are usually given as scheduled, with blood pressure monitoring rather than timing adjustment.

Take-home points:
• Alpha blockers cause a marked first-dose hypotensive effect, requiring the initial dose to be given at bedtime.
• Administering the first dose at night reduces the risk of dizziness, syncope, and falls.
• Monitor blood pressure closely after the first dose and educate patients to rise slowly from bed or sitting positions.

Discussion Section

0 Pulse Checks

No comments

Question 25 :

A 46-year-old man started antihypertensive drug therapy 3 months earlier and is in the office for a follow-up visit. While the nurse is taking his blood pressure, he informs the nurse that he has had some problems with sexual intercourse. Which is the most appropriate response by the nurse?

A. “Not to worry. Eventually, tolerance will develop.” B. “The physician can work with you on changing the dose and/or drugs.” C. “Sexual dysfunction happens with this therapy, and you will learn to accept it.” D. “This is an unusual occurrence, but it is important to stay on your medications.”

Explanation

Many antihypertensive drugs, such as beta blockers and certain diuretics, can cause sexual dysfunction, including decreased libido, erectile dysfunction, or difficulty with ejaculation. These effects can significantly impact adherence to therapy. The most appropriate nursing action is to acknowledge the concern and inform the patient that the physician can adjust the dose or change the medication to minimize side effects while maintaining blood pressure control.

Rationale for correct answer:

B. “The physician can work with you on changing the dose and/or drugs.”
This response shows therapeutic communication and supports collaboration in care. The nurse recognizes that sexual dysfunction is a common adverse effect of some antihypertensives and encourages the patient to discuss it with the provider. Adjusting the dose, changing to a different class (e.g., ACE inhibitor, ARB, or calcium channel blocker), or timing the medication differently can often resolve the issue.

Rationales for incorrect answers:

A. “Not to worry. Eventually, tolerance will develop.”
This statement is inaccurate and dismissive. Tolerance to sexual side effects does not typically occur with antihypertensive therapy, and reassurance without intervention may discourage further communication about the issue.

C. “Sexual dysfunction happens with this therapy, and you will learn to accept it.”
This response is non-therapeutic and lacks empathy. It dismisses the patient’s concern and may lead to nonadherence, as sexual health is an important aspect of quality of life.

D. “This is an unusual occurrence, but it is important to stay on your medications.”
This response provides false reassurance, as sexual dysfunction is actually a common side effect of many antihypertensive drugs. It also ignores the opportunity to address the patient’s concern through collaborative problem-solving.

Take-home points:
• Sexual dysfunction is a common side effect of beta blockers and diuretics used for hypertension.
• The nurse should encourage open communication and refer the patient for possible medication adjustment.
• Empathetic, therapeutic responses improve adherence and patient satisfaction with treatment.

Discussion Section

0 Pulse Checks

No comments

Question 26 :

When a patient is being taught about the potential adverse effects of an ACE inhibitor, which of these effects should the nurse mention as possibly occurring when this drug is taken to treat hypertension? Select all that apply

A. Fatigue B. Nausea C. Dry, nonproductive cough D. Diarrhea E. Dizziness

Explanation

When teaching a client about ACE inhibitors for hypertension, it is important to highlight the potential adverse effects that may occur, including fatigue, dizziness, and a dry, nonproductive cough. Understanding these effects helps clients recognize symptoms early, maintain medication adherence, and seek timely care if complications arise.

Rationale for correct answer:

A. Fatigue
ACE inhibitors can cause vasodilation and a slight decrease in blood pressure, which may lead to feelings of tiredness or fatigue, especially during the initial stages of therapy. Monitoring for fatigue is important as it may affect daily functioning, and dose adjustments or timing changes may be needed.

C. Dry, nonproductive cough
A common adverse effect of ACE inhibitors is a persistent, dry cough caused by accumulation of bradykinin in the respiratory tract. Although not harmful, it can be bothersome enough for clients to request a medication change.

E. Dizziness
Dizziness may occur due to first-dose hypotension or the vasodilatory effects of ACE inhibitors. Clients should be advised to rise slowly from sitting or lying positions to prevent falls and monitor for symptomatic hypotension.

Rationales for incorrect answers:
B. Nausea
Nausea is not a typical adverse effect of ACE inhibitors. Gastrointestinal upset is uncommon and usually mild if it occurs.

D. Diarrhea
Diarrhea is not commonly associated with ACE inhibitor therapy and is not a primary teaching point when discussing adverse effects for hypertension management.

Take-home points:
• ACE inhibitors may cause fatigue, dizziness, and a dry cough, which clients should monitor and report if severe.
• Bradykinin accumulation is responsible for the characteristic dry, nonproductive cough.
• Clients should rise slowly from sitting or lying positions to reduce dizziness from hypotension.

Discussion Section

0 Pulse Checks

No comments

Question 27 :

A patient has a new prescription for an ACE inhibitor. During a review of the patient's list of current medications, which would cause concern for a possible interaction with this new prescription? Select all that apply

A. A benzodiazepine taken as needed for allergies B. A potassium supplement taken daily C. An oral anticoagulant taken daily D. An opioid used for occasional severe pain E. An NSAID taken as needed for headaches

Explanation

ACE inhibitors are used to treat hypertension, heart failure, and diabetic nephropathy by inhibiting the conversion of angiotensin I to angiotensin II, leading to vasodilation, decreased aldosterone secretion, and sodium and water excretion. However, they can cause hyperkalemia and reduced renal perfusion, so combining them with certain other drugs—such as potassium supplements or NSAIDs—can lead to serious interactions that compromise kidney function or electrolyte balance.

Rationale for correct answers:
B. A potassium supplement taken daily
ACE inhibitors reduce aldosterone secretion, leading to potassium retention. Taking a potassium supplement concurrently can result in dangerous hyperkalemia, which may cause cardiac arrhythmias, muscle weakness, or even cardiac arrest. Clients on ACE inhibitors should be advised to avoid potassium supplements and potassium-rich salt substitutes unless specifically directed and monitored by their provider.

E. An NSAID taken as needed for headaches
NSAIDs (e.g., ibuprofen, naproxen) can reduce the antihypertensive effect of ACE inhibitors and impair renal perfusion, especially in patients with dehydration, heart failure, or preexisting renal disease. This combination increases the risk of acute kidney injury due to the additive effects of reduced renal blood flow and sodium retention caused by NSAIDs.

Rationales for incorrect answers:
A. A benzodiazepine taken as needed for allergies
Benzodiazepines (e.g., lorazepam, diazepam) act on the CNS as anxiolytics or sedatives, not as antihistamines. They do not significantly interact with ACE inhibitors to cause hypotension, renal impairment, or electrolyte imbalance.

C. An oral anticoagulant taken daily
Oral anticoagulants (e.g., warfarin) act on the coagulation pathway and have no pharmacologic or metabolic interaction with ACE inhibitors. The combination does not alter drug effectiveness or increase adverse reactions.

D. An opioid used for occasional severe pain
Opioids (e.g., morphine, hydrocodone) primarily depress the CNS and may cause mild hypotension, but occasional use does not typically result in additive or dangerous interactions with ACE inhibitors. The risk is minimal and not a clinical concern.

Take-home points:

ACE inhibitors increase serum potassium, so combining them with potassium supplements or potassium-sparing drugs can cause hyperkalemia.
NSAIDs can blunt the antihypertensive effect of ACE inhibitors and raise the risk of renal impairment.
Always assess renal function, electrolyte balance, and concurrent medication use before starting ACE inhibitor therapy

Discussion Section

0 Pulse Checks

No comments

Question 28 :

The nurse is assessing a patient who will be starting antihypertensive therapy with an ACE inhibitor. Which condition, if present in the patient, would be a reason for cautious use?

A. Asthma B. Rheumatoid arthritis C. Hyperthyroidism D. Renal insufficiency

Explanation

ACE inhibitors are commonly prescribed for hypertension, heart failure, and diabetic nephropathy because they block the conversion of angiotensin I to angiotensin II, leading to vasodilation, reduced blood pressure, and decreased workload on the heart. However, these drugs can also decrease glomerular filtration and raise serum potassium levels, so their use requires caution in clients with renal insufficiency, where kidney function is already compromised.

Rationale for correct answer:
D. Renal insufficiency
ACE inhibitors cause dilation of the efferent arterioles in the kidneys, which can reduce glomerular filtration pressure and lead to worsening renal function in patients with preexisting renal impairment. Additionally, ACE inhibitors can cause hyperkalemia due to decreased aldosterone secretion, which further increases the risk of complications in renal insufficiency.

Rationales for incorrect answers:
A. Asthma
Asthma is not directly affected by ACE inhibitor therapy. However, beta-blockers, not ACE inhibitors, are used cautiously or avoided in asthma due to bronchoconstriction risk. ACE inhibitors do not cause airway constriction but may cause a dry cough, which should not be confused with asthma symptoms.

B. Rheumatoid arthritis
There is no significant interaction or contraindication between ACE inhibitors and rheumatoid arthritis. These medications can be safely used unless the patient is taking other drugs that may affect renal function, such as NSAIDs.

C. Hyperthyroidism
ACE inhibitors do not influence thyroid hormone levels or metabolism. Blood pressure changes in hyperthyroidism are due to increased metabolic activity, and ACE inhibitors can still be used safely for hypertension in these clients.

Take-home points:

Use ACE inhibitors cautiously in clients with renal insufficiency due to the risk of worsening kidney function.
Monitor serum creatinine, BUN, and potassium levels regularly when starting or adjusting ACE inhibitor therapy.
Asthma, rheumatoid arthritis, and hyperthyroidism are not contraindications for ACE inhibitor use

Discussion Section

0 Pulse Checks

No comments

Question 29 :

After discussing lifestyle modifications with the patient who is hypertensive, the nurse will reinforce teaching after the patient makes which statement?

A. “I figure that since I have started on these medications that I don’t have to follow those lifestyle modifications anymore.” B. “I will walk every day at least 20 minutes.” C. “I will weigh myself at the same time every day and report a weight gain of more than 2 pounds.” D. “I think that I can keep track of my blood pressure using a journal to record it.”

Explanation

For clients with hypertension, lifestyle modifications remain essential even after starting on medication therapy. Pharmacologic treatment is often necessary when lifestyle measures alone are insufficient, but it does not replace them. Combining drug therapy with lifestyle changes such as diet modification, weight control, physical activity, and smoking cessation provides the best long-term control of blood pressure and prevention of complications such as stroke, myocardial infarction, and renal damage.

Rationale for correct answer:

A. “I figure that since I have started on these medications that I don’t have to follow those lifestyle modifications anymore.”
This statement demonstrates a misunderstanding of hypertension management. Antihypertensive drugs work best when combined with ongoing lifestyle modifications, including reduced sodium intake, regular exercise, limited alcohol consumption, and stress management. Discontinuing these habits can lead to poor blood pressure control and increased risk of cardiovascular complications despite medication adherence. The nurse should reinforce that lifestyle changes are a lifelong commitment, not a temporary measure.

Rationales for incorrect answers:

B. “I will walk every day at least 20 minutes.”
This reflects positive adherence to exercise recommendations. Regular physical activity, such as brisk walking for 20–30 minutes most days of the week, improves cardiovascular function and helps reduce blood pressure.

C. “I will weigh myself at the same time every day and report a weight gain of more than 2 pounds.”
Daily weight monitoring helps detect fluid retention, especially in clients taking diuretics or those with cardiovascular comorbidities. This is an appropriate and safe self-care behavior.

D. “I think that I can keep track of my blood pressure using a journal to record it.”
Keeping a blood pressure log demonstrates active self-monitoring, which allows both the patient and provider to evaluate treatment effectiveness and make necessary adjustments. This behavior supports effective long-term hypertension management.

Take-home points:
• Lifestyle modifications must continue even after antihypertensive therapy begins.
• Medication and healthy habits work synergistically to maintain optimal blood pressure control.
• Patient education should emphasize that long-term adherence to both pharmacologic and lifestyle measures prevents complications and promotes cardiovascular health.

Discussion Section

0 Pulse Checks

No comments

Question 30 :

The nurse explains to the patient, who needs to start initial drug therapy for hypertension, that treatment usually includes one or more agents from which four drug classes? Select all that apply

A. Diuretics B. Beta blockers C. Aldosterone receptor antagonist D. Angiotensin II receptor blockers E. Calcium channel blockers F. ACE inhibitors G. Direct renin inhibitors H. Alpha-1 adrenergic blockers

Explanation

The initial pharmacologic management of hypertension typically involves agents that target different mechanisms controlling blood pressure, such as fluid volume, vascular resistance, and cardiac output. Evidence-based guidelines recommend beginning therapy with drugs from the following four classes: diuretics, ACE inhibitors, angiotensin II receptor blockers (ARBs), and calcium channel blockers (CCBs). These medications effectively reduce blood pressure, decrease cardiovascular risk, and are well-tolerated for long-term therapy.

Rationale for correct answers:

A. Diuretics
Thiazide-type diuretics (e.g., hydrochlorothiazide) are often the first-line agents for hypertension. They lower blood pressure by reducing blood volume through sodium and water excretion and by decreasing peripheral vascular resistance. They are particularly effective in older adults and clients with salt-sensitive hypertension.

D. Angiotensin II receptor blockers (ARBs)
ARBs (e.g., losartan, valsartan) block the binding of angiotensin II to its receptors, leading to vasodilation and reduced aldosterone-mediated sodium retention. They are often used when clients cannot tolerate ACE inhibitors due to cough or angioedema.

E. Calcium channel blockers (CCBs)
CCBs (e.g., amlodipine, diltiazem) lower blood pressure by inhibiting calcium influx into vascular smooth muscle and cardiac cells, causing arterial relaxation and vasodilation. They are particularly effective in African American clients and those with isolated systolic hypertension.

F. ACE inhibitors
ACE inhibitors (e.g., lisinopril, captopril) inhibit the conversion of angiotensin I to angiotensin II, leading to vasodilation, reduced aldosterone secretion, and decreased afterload. They are especially beneficial for clients with diabetes or chronic kidney disease due to their renal-protective effects.

Rationales for incorrect answers:

B. Beta blockers
Although beta blockers (e.g., propranolol, metoprolol) can lower blood pressure, they are no longer considered first-line therapy for uncomplicated hypertension. They are more commonly used when there are coexisting conditions such as heart failure, post-MI, or arrhythmias.

C. Aldosterone receptor antagonist
These agents (e.g., spironolactone, eplerenone) are not first-line drugs but are used as add-on therapy in resistant hypertension or when hyperaldosteronism is suspected.

G. Direct renin inhibitors
Aliskiren inhibits renin activity and decreases angiotensin II production but is not typically first-line due to limited long-term outcome data and potential for adverse renal effects when combined with ACE inhibitors or ARBs.

H. Alpha-1 adrenergic blockers
These medications (e.g., doxazosin, prazosin) are used as adjuncts, mainly in clients with benign prostatic hyperplasia (BPH). They are not preferred as initial therapy because of risks of orthostatic hypotension.

Take-home points:
• First-line antihypertensive agents include diuretics, ACE inhibitors, ARBs, and calcium channel blockers.
• Combination therapy is often required to achieve target blood pressure control.
• Drug selection should be individualized based on comorbidities, age, and drug tolerance

Discussion Section

0 Pulse Checks

No comments

End of Questions

Exams on Drugs Used to Treat Hypertension

Practice Exercise 1

Review Practice Mode Take Exam

Practice Exercise 2

Review Practice Mode Take Exam

Practice Exercise 3

Review Practice Mode Take Exam

Practice Exercise 4

Review Practice Mode Take Exam

Practice Exercise 5

Review Practice Mode Take Exam

Practice Exercise 6

Review Practice Mode Take Exam

Practice Exercise 7

Review Practice Mode Take Exam

Comprehensive Questions

Review Practice Mode Take Exam

Custom Exams

Click here to login

Lessons

Table of Contents

Objectives
Introduction
Practice Exercise 1
Pharmacologic Management Of Hypertension
Practice Exercise 2
ACE Inhibitors (angiotensin-converting Enzyme Inhibitors)
Practice Exercise 3
Angiotensin Receptor Blockers (ARBs)
Practice Exercise 4
Calcium Channel Blockers (CCBs)
Practice Exercise 5
Adrenergic Antagonists (sympatholytics)
Practice Exercise 6
Direct Vasodilators
Practice Exercise 7
Summary
Comprehensive Questions

Notes Highlighting is available once you sign in. Login Here.

Objectives

Explain how hypertension is defined and classified.
Explain the effects of cardiac output, peripheral resistance, and blood volume on blood pressure.
Discuss how the vasomotor center, baroreceptors, chemoreceptors, emotions, and hormones influence blood pressure.
Summarize the long-term consequences of untreated hypertension.
Explain how diuretics lower blood pressure through fluid loss and long-term vasodilation.
Describe ACE inhibitors’ RAAS inhibition, preload/afterload reduction, and bradykinin-mediated effects.
Explain how ARBs block angiotensin II at AT₁ receptors to reduce BP and protect the heart and kidneys.
Differentiate calcium channel blockers’ vascular and cardiac effects in lowering BP and managing arrhythmias.
Identify the therapeutic uses of diuretics, ACE inhibitors, ARBs, and CCBs in hypertension, heart failure, CKD, angina, and arrhythmias.
Recognize key adverse effects and electrolyte or metabolic disturbances associated with each antihypertensive class.
Demonstrate appropriate nursing monitoring, including vital signs, labs, fluid status, and ECG changes.
Teach patients proper medication adherence, lifestyle modifications, dietary guidance, and symptom reporting.

Take Practice Test on Objectives

Introduction

Hypertension

How Hypertension Is Defined & Classified

• Definition:
Hypertension is persistently elevated arterial blood pressure (BP) that exceeds the normal expected range for age and health status.

It represents a chronic condition in which the force of blood against the arterial walls remains elevated over time, leading to progressive vascular injury and increased cardiac workload.

In most current guidelines, hypertension is diagnosed when BP ≥ 130/80 mmHg (American Heart Association, 2017) when measured on at least two separate occasions under standardized conditions.

BP measurement must be accurate—using the correct cuff size, with the patient seated, arm supported at heart level, and after several minutes of rest—to avoid false elevation or white-coat hypertension.

Ambulatory or home BP monitoring may be used to confirm diagnosis and identify masked hypertension (normal clinic BP but elevated home readings).

Classification (by stage):
The staging of hypertension helps clinicians determine treatment urgency and long-term management goals.
o Normal: < 120/80 mmHg → indicates optimal cardiovascular status.
o Elevated: 120–129 / < 80 mmHg → lifestyle modification is key; pharmacologic therapy usually not yet indicated.
o Stage 1 Hypertension: 130–139 / 80–89 mmHg → may require drug therapy in patients with comorbidities (e.g., diabetes, CKD, CAD).
o Stage 2 Hypertension: ≥ 140 / ≥ 90 mmHg → pharmacologic therapy strongly indicated, often using two or more agents.
o Hypertensive Crisis: > 180 / > 120 mmHg → requires immediate medical evaluation to prevent acute target-organ damage (e.g., encephalopathy, heart failure, renal failure).

Primary (Essential) vs. Secondary Hypertension:
o Primary (Essential) Hypertension:

Accounts for approximately 90–95% of all cases.
Has no single identifiable cause, but develops from complex interactions among genetic, environmental, and lifestyle factors, including:
- Family history of hypertension
- Increased sodium intake
- Obesity and physical inactivity
- Excess alcohol consumption
- Chronic stress
- Insulin resistance and metabolic syndrome
Pathophysiology involves enhanced sympathetic activity, endothelial dysfunction, sodium retention, and arterial remodeling.
o Secondary Hypertension:
Represents 5–10% of cases, where BP elevation has a specific underlying cause.
Common causes include:
- Renal disease: chronic kidney disease, renal artery stenosis
- Endocrine disorders: Cushing’s syndrome, hyperthyroidism, primary aldosteronism, pheochromocytoma
- Medications: oral contraceptives, corticosteroids, NSAIDs, decongestants
- Pregnancy-induced hypertension (PIH) or preeclampsia
Management involves treating the underlying cause, often resulting in normalization of BP once corrected.

Hemodynamic Determinants of Blood Pressure

Blood pressure is determined by a delicate interplay of cardiac output (CO), peripheral vascular resistance (PVR), and blood volume. Each determinant represents a major target for antihypertensive therapy.

• Cardiac Output (CO):
CO = Heart Rate (HR) × Stroke Volume (SV)

Heart Rate (HR): Determined primarily by autonomic nervous system balance—sympathetic stimulation increases HR, while parasympathetic stimulation (vagal tone) decreases HR.
Stroke Volume (SV): Depends on myocardial contractility, venous return (preload), and afterload (resistance against which the heart pumps).
When CO increases (due to tachycardia, increased contractility, or expanded blood volume), BP rises unless compensated by a reduction in PVR.
Insight: Drugs such as beta-blockers and calcium channel blockers (non-dihydropyridines) lower BP partly by reducing CO.

• Peripheral Vascular Resistance (PVR):

PVR is the resistance to blood flow within the arterioles, determined largely by arteriolar smooth muscle tone.
Vasoconstriction increases PVR and elevates BP, while vasodilation lowers PVR and reduces BP.
Arterioles are the major resistance vessels, and their tone is influenced by the autonomic nervous system, local tissue factors (e.g., nitric oxide, endothelin), and hormones such as angiotensin II and epinephrine.
Insight: Most antihypertensive drugs, such as ACE inhibitors, ARBs, and CCBs, act by modulating arteriolar tone to decrease PVR.

• Blood Volume:

Represents the total amount of circulating blood, mainly influenced by renal sodium and water handling.
When plasma volume expands (e.g., due to sodium retention, kidney disease, or excess aldosterone), venous return and preload rise, leading to increased CO and BP.
Conversely, volume depletion lowers BP.
Insight: Diuretics are the cornerstone therapy targeting volume control in hypertension by promoting sodium and water excretion.

Summary Concept:
Hypertension can result from increased cardiac output, elevated peripheral resistance, or expanded intravascular volume, or a combination of these. Therefore, most antihypertensive agents work by decreasing CO, reducing PVR, or lowering blood volume.

Neural, Hormonal, and Central Regulation of Blood Pressure

The cardiovascular system maintains BP through moment-to-moment regulation (via neural mechanisms) and long-term control (via hormonal and renal feedback). Understanding these helps explain drug actions and side effects.

• Vasomotor Center (in Medulla Oblongata):

Located within the medulla, this center integrates input from baroreceptors, chemoreceptors, and higher cortical centers.
It controls sympathetic outflow to arterioles and the heart, thereby regulating vascular tone and cardiac output.
Sympathetic activation → increased HR, contractility, and vasoconstriction → increased BP.
Parasympathetic stimulation (via the vagus nerve) → decreased HR → lower BP.
Insight: Central acting agents like clonidine act directly on the vasomotor center to suppress sympathetic outflow.

• Baroreceptors (in Carotid Sinus and Aortic Arch):

These stretch-sensitive mechanoreceptors continuously monitor BP changes.
If BP rises: increased baroreceptor firing triggers reflex vasodilation and decreased HR (via vagal activation).
If BP falls: decreased baroreceptor firing causes reflex vasoconstriction and tachycardia through increased sympathetic tone.
Over time, in chronic hypertension, baroreceptors reset to a higher threshold, diminishing their sensitivity—a key reason hypertension becomes self-perpetuating.

• Chemoreceptors (in Carotid & Aortic Bodies):

Respond to changes in oxygen (O₂), carbon dioxide (CO₂), and pH levels in blood.
When O₂ levels drop or CO₂ rises, they trigger sympathetic activation, leading to vasoconstriction and increased BP to improve tissue perfusion.
Their influence on BP is less dominant than baroreceptors but significant during hypoxia, acidosis, or respiratory compromise.

• Emotional & Higher Brain Centers:

Emotions such as fear, anger, stress, and anxiety stimulate the hypothalamus and limbic system, which increase sympathetic discharge.
Catecholamine release (epinephrine, norepinephrine) during stress episodes causes transient hypertension.
Insight: Teaching relaxation techniques and stress management is part of non-pharmacologic BP control.

• Hormonal Influences:
Hormones maintain long-term regulation of BP via modulation of vascular tone and renal handling of sodium/water.
o Renin-Angiotensin-Aldosterone System (RAAS):
- Activated by decreased renal perfusion pressure, low sodium, or sympathetic stimulation.
- Renin, secreted by the kidneys, converts angiotensinogen → angiotensin I, which is then converted by ACE to angiotensin II.
- Angiotensin II is a potent vasoconstrictor and stimulates aldosterone secretion from the adrenal cortex, leading to sodium and water retention.
- Chronic activation of RAAS contributes to sustained hypertension and vascular remodeling.
- Pharmacologic control: achieved via ACE inhibitors, ARBs, and direct renin inhibitors.
o Antidiuretic Hormone (ADH / Vasopressin):
- Released from the posterior pituitary in response to increased plasma osmolality or decreased blood volume.
- Promotes water reabsorption in renal collecting ducts, increasing plasma volume and BP.
o Natriuretic Peptides (ANP & BNP):
- Released from atrial and ventricular myocardium in response to stretch caused by volume overload.
- Promote vasodilation, natriuresis, and diuresis, counteracting the effects of RAAS.
- Serve as important biomarkers in heart failure and volume-related hypertension.

Long-Term Consequences of Untreated Hypertension

Persistent elevation in blood pressure exerts mechanical stress on arteries, leading to endothelial injury, arterial thickening, and progressive target-organ damage. Hypertension thus affects every major organ system.

• Heart (Cardiac System):

Left Ventricular Hypertrophy (LVH): The heart must pump against increased afterload, causing myocardial thickening, reduced compliance, and eventual heart failure.
Coronary Artery Disease (CAD): High BP accelerates atherosclerosis, increasing the risk of angina and myocardial infarction (MI).
Heart Failure (HF): Chronic pressure overload leads to weakened myocardium and reduced ejection fraction.

• Vascular System:

Aneurysm Formation: Prolonged arterial pressure weakens vessel walls, predisposing to aortic aneurysms or cerebral aneurysms.
Arteriosclerosis & Microvascular Damage: Chronic strain leads to loss of arterial elasticity, lumen narrowing, and tissue ischemia.
Stroke Risk: Both ischemic and hemorrhagic stroke risk increase due to vessel rupture or thrombosis.

• Renal System:

Nephrosclerosis: Chronic hypertension damages renal arterioles and glomeruli, causing renal ischemia, proteinuria, and chronic kidney disease (CKD).
End-Stage Renal Disease (ESRD): Progressive scarring leads to dialysis dependency if uncontrolled.
Insight: BP control is vital in protecting renal function, especially in diabetic patients.

• Ophthalmic (Eye) Changes:

Hypertensive Retinopathy: Elevated pressure damages retinal blood vessels, causing hemorrhages, exudates, narrowing, and papilledema.
These changes correlate with systemic vascular damage and can lead to vision loss.
Routine fundoscopic examination helps evaluate severity and progression.

• Central Nervous System (CNS):

Cerebrovascular Accidents (Stroke): Chronic vascular damage increases risk of both ischemic and hemorrhagic stroke.
Transient Ischemic Attacks (TIAs): Brief episodes of cerebral ischemia, warning signs of impending stroke.
Cognitive Decline and Vascular Dementia: Long-term microvascular injury in the brain leads to progressive cognitive impairment.

• Other Organs:

Peripheral Arterial Disease (PAD): Atherosclerosis in peripheral vessels causes pain, poor wound healing, and potential gangrene.
Aortic Dissection: Sudden tear in the aortic wall due to chronic hypertension—a life-threatening emergency.

Clinical Summary:
Hypertension is called the “silent killer” because it often produces no early symptoms, yet causes irreversible organ damage over years. Early detection, lifestyle modification, and pharmacologic control are essential to prevent morbidity and mortality.

Take Practice Test on Introduction

Take Practice Test on Practice Exercise 1

Pharmacologic Management Of Hypertension

DIURETICS

Overview:
Diuretics are among the most widely prescribed antihypertensive agents and are considered first-line therapy for most patients with mild to moderate hypertension. These drugs lower blood pressure primarily by reducing blood volume, but with continued therapy, they also cause long-term vasodilation and reduced peripheral vascular resistance.
They play a vital role not only in hypertension management but also in heart failure, chronic kidney disease, and edema associated with hepatic or renal disorders.

Drugs:

• Thiazide Diuretics: Hydrochlorothiazide (HCTZ), Chlorothiazide, Chlorthalidone, Indapamide
• Loop Diuretics: Furosemide, Bumetanide, Torsemide, Ethacrynic acid (rarely used)
• Potassium-Sparing Diuretics: Spironolactone, Eplerenone, Amiloride, Triamterene
• (Additional Note: Combination diuretics such as HCTZ with amiloride or triamterene are often used to balance potassium effects.)

Mechanism of Action:

General Mechanism:
Diuretics reduce blood pressure primarily through increased renal excretion of sodium and water, leading to a decrease in blood volume, cardiac output, and venous return. Over time, despite partial recovery of plasma volume, there is a sustained reduction in peripheral resistance, which maintains the antihypertensive effect.

Thiazide Diuretics

• Act on the distal convoluted tubule to inhibit the Na⁺/Cl⁻ symporter, blocking sodium and chloride reabsorption.
• This promotes excretion of sodium, chloride, and water, decreasing extracellular fluid volume and venous return.
• Over long-term therapy, thiazides cause arteriolar dilation and reduced peripheral vascular resistance, even when plasma volume normalizes.
• Note: Thiazides are less effective in patients with severe renal impairment (CrCl < 30 mL/min).

Loop Diuretics

• Act on the ascending limb of the loop of Henle, where they inhibit the Na⁺/K⁺/2Cl⁻ cotransporter, leading to profound excretion of sodium, chloride, potassium, calcium, and water.
• They produce the most potent diuretic effect, making them useful in severe hypertension, edematous states, and heart failure when rapid fluid removal is required.
• Unlike thiazides, they remain effective even in renal impairment.

Potassium-Sparing Diuretics

• Act on the late distal tubule and collecting ducts, where they inhibit sodium reabsorption and reduce potassium excretion.
• Spironolactone and Eplerenone: Are aldosterone receptor antagonists, preventing aldosterone-mediated sodium retention and potassium loss.
• Amiloride and Triamterene: Directly block sodium channels in the distal nephron independent of aldosterone.
• They are weak diuretics on their own but are valuable in combination therapy to prevent hypokalemia caused by thiazides or loops.

Primary Actions:

• Decrease Blood Volume → Lower Cardiac Output → Reduced Blood Pressure:
All diuretics initially decrease blood pressure by reducing plasma and extracellular fluid volume, which decreases venous return (preload) and cardiac output.

• Long-Term Reduction of Peripheral Vascular Resistance (PVR):
After several weeks of therapy, cardiac output normalizes, but blood pressure remains low due to direct vasodilatory effects and reduced sodium content in arteriolar walls, leading to decreased responsiveness to vasoconstrictors.

• Enhanced Sodium and Water Excretion:
Reduced sodium load leads to decreased vascular stiffness and improved endothelial function.

• First-Line Therapy:
Thiazides, particularly chlorthalidone and hydrochlorothiazide, are recommended as first-line agents in most treatment guidelines (such as JNC 8 and ACC/AHA) for uncomplicated hypertension due to their proven efficacy and cost-effectiveness.

• Adjunctive Use:
Loop and potassium-sparing diuretics are often used in combination therapy for resistant hypertension or in patients with comorbid conditions such as heart failure, chronic kidney disease, or cirrhosis with ascites.

Adverse Effects / Insights:

Electrolyte Imbalances:
• Hypokalemia (Thiazides and Loops):
Loss of potassium can lead to muscle weakness, fatigue, leg cramps, and cardiac arrhythmias.

Insight: Monitor serum potassium levels regularly; encourage dietary potassium intake (bananas, oranges, leafy greens) or prescribe supplements if necessary.
Teach patients on digitalis therapy that hypokalemia increases the risk of digoxin toxicity.

• Hyperkalemia (Potassium-Sparing Diuretics):
May cause cardiac conduction abnormalities if combined with ACE inhibitors, ARBs, or potassium supplements.

Insight: Avoid concurrent potassium supplements or salt substitutes containing potassium.
Monitor serum potassium frequently, especially in elderly or renal-impaired patients.

• Hyponatremia:
Excessive sodium loss may cause confusion, weakness, and seizures, especially in the elderly.

Insight: Monitor serum sodium and mental status changes.

• Hypocalcemia (Loop Diuretics) vs. Hypercalcemia (Thiazides):

Loops increase calcium excretion; thiazides reduce it.
Clinical relevance: Thiazides are preferred in patients with osteoporosis; loops are preferred in hypercalcemia.

Volume Depletion & Orthostatic Hypotension:
• Excessive diuresis can result in dehydration, dizziness, fainting, and postural hypotension, increasing fall risk—particularly in older adults.
• Insight:

Monitor vital signs and orthostatic BP changes.
Instruct patients to change positions slowly (sit before standing).
Encourage adequate fluid intake unless contraindicated.

Metabolic Effects:
• Hyperglycemia:
Thiazides may impair glucose tolerance by reducing insulin secretion or sensitivity.

Insight: Monitor blood glucose levels in diabetic or prediabetic patients.

• Hyperuricemia:
Thiazides and loops increase uric acid reabsorption, potentially triggering gout attacks.

Insight: Use cautiously in patients with gout; encourage hydration to reduce uric acid crystallization.

• Hyperlipidemia (mild):
Temporary increase in LDL and triglycerides may occur but typically resolves with long-term use.

Other Adverse Reactions:
• Ototoxicity (Loop Diuretics, especially Furosemide):
High IV doses or combination with other ototoxic drugs (aminoglycosides) can cause hearing loss or tinnitus.

Insight: Administer IV furosemide slowly; report any hearing changes immediately.

• Endocrine Effects (Spironolactone):
Because it is a steroid analog, spironolactone may cause gynecomastia, menstrual irregularities, or impotence.

Eplerenone has fewer endocrine side effects and may be preferred.

Monitoring and Nursing Responsibilities:
• Assess baseline weight, vital signs, I&O, serum electrolytes, BUN, and creatinine before initiation.
• Evaluate urine output and BP regularly to determine drug effectiveness.
• Teach patients to take diuretics in the morning to prevent nocturia.
• Advise avoidance of alcohol and hot weather, which can worsen hypotension.
• Reinforce importance of adherence even when symptoms improve—hypertension is often asymptomatic.
• Report any signs of muscle cramps, palpitations, dizziness, or swelling to the provider promptly.

Patient Education Highlights:
• Take medication early in the day to minimize nighttime urination.
• Maintain adequate hydration unless otherwise restricted.
• Consume potassium-rich foods if prescribed a thiazide or loop diuretic; avoid them if on potassium-sparing agents.
• Do not self-adjust doses—increasing doses without medical guidance can cause severe dehydration or electrolyte imbalance.
• Rise slowly from lying or sitting positions to reduce dizziness.
• Weigh daily and report a gain of >2 lbs (1 kg) in 24 hours, which may indicate fluid retention.
• Be aware of possible photosensitivity—use sunscreen and protective clothing.

Take Practice Test on Pharmacologic Management Of Hypertension

Take Practice Test on Practice Exercise 2

ACE Inhibitors (angiotensin-converting Enzyme Inhibitors)

Drug examples:

Captopril, Enalapril, Lisinopril, Ramipril, Benazepril, Perindopril, Quinapril, Fosinopril, Trandolapril

ACE inhibitors are one of the cornerstones of cardiovascular pharmacotherapy. They are among the most widely prescribed medications for the management of hypertension, heart failure, and diabetic kidney disease. The drugs within this class vary in duration of action, route of elimination, and dosing frequency, but they share a common mechanism of action and therapeutic profile.

• Captopril – The first ACE inhibitor developed; short-acting and useful for initial titration or acute BP control.
• Enalapril – Commonly used; available orally and intravenously.
• Lisinopril – Long-acting, water-soluble (not a prodrug); suitable for once-daily dosing.
• Ramipril, Perindopril, Quinapril, Trandolapril – Lipophilic prodrugs that provide sustained 24-hour BP control.
• Fosinopril – Unique because it is eliminated by both hepatic and renal pathways, making it safer in patients with mild-to-moderate renal impairment.

Mechanism of Action:

ACE inhibitors target the Renin–Angiotensin–Aldosterone System (RAAS) — a key hormonal system that regulates blood pressure, vascular tone, and fluid balance.

Stepwise Mechanism:

Renin Release: The kidneys secrete renin in response to decreased blood flow, reduced sodium levels, or sympathetic activation.
Angiotensin I Formation: Renin acts on angiotensinogen (produced by the liver) to form angiotensin I, an inactive precursor.
Angiotensin II Conversion: The ACE enzyme, primarily located in pulmonary endothelium, converts angiotensin I into angiotensin II, a potent vasoconstrictor and stimulator of aldosterone release.
Inhibition by ACE Inhibitors: ACE inhibitors block this conversion, reducing the formation of angiotensin II and preventing its hypertensive and volume-retentive effects.

Cardiovascular and Renal Effects of ACE Inhibition:

• ↓ Angiotensin II → Vasodilation:
Reduction in angiotensin II causes systemic arteriolar dilation, leading to decreased systemic vascular resistance (afterload) and lower arterial pressure.

• ↓ Aldosterone Secretion → Decreased Sodium and Water Retention:
Decreased aldosterone production reduces renal sodium reabsorption, causing mild diuresis and reduced blood volume (preload), which lowers venous return to the heart.

• ↓ Sympathetic Nervous System Activity:
ACE inhibition blunts reflex sympathetic activation and reduces catecholamine release, helping prevent reflex tachycardia that occurs with many other antihypertensives.

• ↓ Cardiac Remodeling and Hypertrophy:
Chronic angiotensin II stimulation causes myocardial hypertrophy and fibrosis. ACE inhibitors block this remodeling process, preserving cardiac structure and function, which is especially beneficial in heart failure and post-MI patients.

• ↑ Bradykinin Levels:
ACE also degrades bradykinin, a vasodilatory peptide. Inhibition of ACE therefore increases bradykinin levels, leading to enhanced vasodilation via nitric oxide and prostacyclin release.
However, bradykinin accumulation is also responsible for dry cough and angioedema—unique adverse effects of this class.

Additional Pharmacologic Characteristics:

• Lack of Reflex Tachycardia: ACE inhibitors lower BP without increasing heart rate, making them ideal for long-term management.
• Effective in Diverse Populations: These agents are effective even in patients with normal or low renin levels, although response may be blunted in some Black or elderly patients unless combined with a diuretic.
• Prodrugs and Active Metabolites:

Enalapril → Enalaprilat
Ramipril → Ramiprilat
These active metabolites provide sustained BP control.
• Captopril: Has a short half-life (6–8 hours), making it suitable for dose adjustment and early titration in sensitive patients.
• Fosinopril: Dual elimination (renal + hepatic) → suitable for use in patients with renal impairment.

Primary Actions:

ACE inhibitors act both on the vasculature and the heart, providing hemodynamic and structural benefits.

• Reduce Both Preload and Afterload:

By decreasing circulating volume (via aldosterone suppression), preload is reduced.
By reducing arterial resistance, afterload is decreased.
Together, these effects reduce myocardial oxygen demand and cardiac workload.

• Effective Blood Pressure Control:
They provide steady, long-term BP reduction without significant changes in heart rate or cardiac output.

• Improve Survival and Morbidity in Heart Failure:
ACE inhibitors reduce mortality by decreasing ventricular hypertrophy, improving ejection fraction, and preventing progression of heart failure.

• Post–Myocardial Infarction Protection:
Early initiation post-MI improves ventricular remodeling and reduces sudden cardiac death and recurrent ischemic events.

• Renal Protection (Diabetic and Non-Diabetic):

Reduce intraglomerular pressure, proteinuria, and glomerulosclerosis.
Slow progression of diabetic nephropathy and chronic kidney disease (CKD).

• End-Organ Protection:
Long-term therapy protects heart, kidneys, and brain from hypertensive vascular damage.

Therapeutic Uses:

Hypertension:
- Considered first-line therapy, particularly beneficial in patients with diabetes, heart failure, or CKD.
- Often combined with thiazide diuretics or calcium channel blockers for enhanced BP control.
Heart Failure (HFrEF):
- Reduces symptoms, hospitalizations, and mortality.
- Often combined with beta-blockers and diuretics.
Post–Myocardial Infarction:
- Initiated within 24–48 hours of MI to prevent cardiac remodeling and improve long-term survival.
Diabetic Nephropathy and Proteinuria:
- Prevents glomerular hyperfiltration and slows progression to end-stage renal disease (ESRD).
Chronic Kidney Disease:
- Beneficial in non-diabetic CKD with proteinuria; reduces intraglomerular hypertension.
Other Off-Label Uses:
- Scleroderma renal crisis, prevention of stroke in high-risk patients, and management of left ventricular dysfunction.

Adverse Effects / Insights:

Dry, Persistent Cough:

• Caused by bradykinin accumulation in the respiratory tract.
• Occurs in 10–20% of patients and is more frequent in females and nonsmokers.
• Insight:

Educate patients that this cough is non-productive and benign.
If intolerable, provider may switch to an ARB (Angiotensin II Receptor Blocker), which does not elevate bradykinin.

Hyperkalemia:

• Reduced aldosterone → decreased potassium excretion → elevated serum potassium levels.
• Risk factors:

Use of potassium-sparing diuretics (spironolactone, amiloride)
Potassium supplements or salt substitutes
Renal impairment, diabetes, or advanced age
• Clinical Signs: Muscle weakness, paresthesias, cardiac dysrhythmias.
• Insight:
Monitor serum potassium closely.
Advise patients to avoid potassium-rich foods (bananas, oranges, salt substitutes).
Report any palpitations or muscle twitching.

Angioedema (Rare but Life-Threatening):

• Caused by bradykinin-mediated vascular permeability leading to swelling of the lips, tongue, face, and airway.
• May occur anytime during therapy, even after years of use.
• Insight:

Discontinue drug immediately.
Treat with epinephrine and airway management if airway compromise develops.
Contraindicated in patients with a history of ACE inhibitor–induced angioedema.

First-Dose Hypotension:

• Seen in volume-depleted patients (e.g., on diuretics or with heart failure).
• Caused by sudden reduction in angiotensin II–mediated vasoconstriction.
• Insight:

Administer first dose at bedtime to reduce fall risk.
Monitor BP closely after first administration.
Warn patients to rise slowly from sitting or lying positions.

Renal Impairment (Rare but Serious):

• In patients with bilateral renal artery stenosis, ACE inhibition decreases glomerular filtration pressure → acute renal failure.
• Insight:

Monitor BUN and creatinine before and during therapy.
Discontinue if serum creatinine doubles or GFR declines sharply.
Avoid combination with NSAIDs, which further impair renal blood flow.

Fetal Toxicity:

• ACE inhibitors are teratogenic, especially in 2nd and 3rd trimesters.
• Can cause fetal renal failure, oligohydramnios, skull hypoplasia, or fetal death.
• Insight:

Contraindicated in pregnancy and lactation.
Advise women of childbearing age to use reliable contraception.
If pregnancy occurs, discontinue immediately and notify provider.

Other Possible Effects:

• Rash and pruritus (especially with captopril).
• Taste disturbances (metallic or loss of taste).
• Fatigue, dizziness, mild orthostatic hypotension.

Monitoring Parameters:

• Blood Pressure: Monitor baseline and periodic readings; observe for hypotension after first dose.
• Serum Potassium and Sodium: To detect hyperkalemia or hyponatremia.
• Renal Function Tests: BUN, serum creatinine, and GFR.
• Signs of Angioedema or Persistent Cough: Report immediately.
• Weight: To detect early fluid retention or dehydration.

Patient Education:

• Medication Adherence:
Take the drug at the same time daily, even if feeling well. Do not stop abruptly.

• Postural Safety:
Rise slowly from sitting or lying positions to prevent dizziness or fainting.

• Dietary Advice:
Avoid salt substitutes and potassium supplements unless prescribed. Maintain a balanced, low-sodium diet.

• Symptom Reporting:
Report facial or throat swelling, persistent cough, muscle weakness, or dizziness immediately.

• Drug Interactions:
Avoid NSAIDs (ibuprofen, naproxen) as they can reduce the antihypertensive effect and impair renal function.

• Pregnancy Warning:
Notify healthcare provider immediately if pregnancy occurs or is suspected.

• Lifestyle Reinforcement:
Combine therapy with diet modification, exercise, weight control, and smoking cessation for optimal cardiovascular benefit.

Take Practice Test on ACE Inhibitors (angiotensin-converting Enzyme Inhibitors)

Take Practice Test on Practice Exercise 3

Angiotensin Receptor Blockers (ARBs)

Drug examples:

Losartan, Valsartan, Irbesartan, Candesartan, Olmesartan, Telmisartan, Eprosartan, Azilsartan

ARBs (Angiotensin II Receptor Blockers) are a major class of antihypertensive medications that act on the renin–angiotensin–aldosterone system (RAAS)—a key hormonal system responsible for regulating blood pressure, fluid balance, and vascular resistance.
These agents provide effects similar to ACE inhibitors but are better tolerated, particularly in patients who experience cough or angioedema from ACE inhibitor therapy.

Each drug in this class has unique pharmacokinetic characteristics:

Losartan: The first ARB developed; has an active metabolite (EXP3174) that is more potent and longer-acting than the parent drug.
Valsartan: Potent, once-daily dosing, especially beneficial in heart failure.
Irbesartan: High oral bioavailability and longer half-life (up to 24 hours), ideal for once-daily dosing.
Candesartan: Long-acting and highly selective for AT₁ receptors.
Telmisartan: Has additional PPAR-γ agonist activity, potentially improving insulin sensitivity and lipid metabolism.
Olmesartan: Potent vasodilator, suitable for patients requiring robust BP control.
Eprosartan and Azilsartan: Rarely used but effective; Azilsartan provides the most pronounced and consistent BP reduction among ARBs.

Mechanism of Action:

ARBs selectively block the binding of angiotensin II—a powerful vasoconstrictor—to its AT₁ receptors located on vascular smooth muscle, the adrenal cortex, the kidneys, and the heart.
By doing so, they interrupt the final common pathway of the RAAS, producing widespread cardiovascular and renal benefits.

Key Mechanistic Steps:

Renin Release (Unchanged): The kidneys release renin in response to decreased renal perfusion.
Formation of Angiotensin I and II: Angiotensinogen is converted to angiotensin I by renin, and angiotensin I is then converted to angiotensin II via ACE.
Blockade of AT₁ Receptors: ARBs prevent angiotensin II from binding to AT₁ receptors.
Result:
- No vasoconstriction → Decreased peripheral vascular resistance and BP.
- No aldosterone release → Reduced sodium and water retention → Decreased blood volume.
- Reduced sympathetic activation → Stabilized heart rate and reduced myocardial workload.
- Increased renal blood flow → Improved renal perfusion and decreased intraglomerular pressure.

Important Distinction from ACE Inhibitors:
Unlike ACE inhibitors, ARBs do not inhibit bradykinin breakdown, meaning they do not increase bradykinin levels.
As a result, they are much less likely to cause dry cough or angioedema, making them an excellent alternative when ACE inhibitors are not tolerated.

Key Pharmacologic Effects:

↓ Systemic Vascular Resistance (Afterload):
- ARBs induce smooth muscle relaxation in arterioles, causing vasodilation and reduction in afterload (resistance the heart must pump against).
- This leads to a lower systolic and diastolic BP without reflex tachycardia.
↓ Aldosterone Secretion → ↓ Sodium and Water Retention:
- By preventing angiotensin II from acting on the adrenal cortex, ARBs decrease aldosterone production.
- This reduces sodium reabsorption and water retention, thereby lowering plasma volume and preload (venous return).
↑ Renal Blood Flow and ↓ Glomerular Pressure:
- By dilating the efferent arterioles of the nephron, ARBs reduce intraglomerular hypertension, thereby protecting the kidneys from progressive damage.
- This mechanism is especially valuable in patients with diabetic nephropathy.
↓ Cardiac Remodeling and Hypertrophy:
- ARBs counteract the long-term deleterious effects of angiotensin II on cardiac myocytes and fibroblasts, reducing fibrosis and hypertrophy.
- This improves ventricular compliance and ejection fraction in patients with chronic heart failure.
Improved Endothelial Function:
- By reducing oxidative stress and vascular inflammation, ARBs improve arterial compliance and microcirculatory function, enhancing overall tissue perfusion.

Primary Actions:

• Lower Blood Pressure Effectively and Smoothly:
ARBs produce a gradual and sustained BP reduction without major fluctuations or reflex increases in heart rate.
This makes them suitable for long-term control of hypertension and maintenance therapy.

• Provide Renal and Cardiovascular Protection:
Similar to ACE inhibitors, ARBs protect the kidneys, heart, and vasculature from hypertensive damage.
They are especially beneficial in patients with diabetes, CKD, or heart failure.

• Improve Survival and Reduce Hospitalization in Heart Failure:
Clinical trials (e.g., VALIANT, CHARM) demonstrate that ARBs reduce morbidity and mortality in patients with systolic heart failure and post–myocardial infarction left ventricular dysfunction.

• Alternative to ACE Inhibitors:
Ideal for patients who cannot tolerate ACE inhibitors due to persistent cough or angioedema.

• Preserve Renal Function:
By reducing intraglomerular pressure, ARBs help limit proteinuria and slow progression of nephropathy, particularly in diabetic and hypertensive renal disease.

Therapeutic Uses:

Hypertension:
- First-line therapy either as monotherapy or in combination with thiazide diuretics or calcium channel blockers.
- Particularly useful in diabetic patients, those with left ventricular hypertrophy, or those intolerant to ACE inhibitors.
Heart Failure (HFrEF):
- Reduce preload and afterload, improving cardiac output and symptom control.
- Beneficial when ACE inhibitors are contraindicated or not tolerated.
Diabetic Nephropathy and Proteinuria:
- Decrease glomerular capillary pressure and reduce albuminuria, slowing disease progression.
- Recommended for both Type 1 and Type 2 diabetes with microalbuminuria.
Post–Myocardial Infarction:
- Help prevent ventricular remodeling, reduce recurrent MI, and improve survival rates.
- Used when ACE inhibitors are not tolerated.
Stroke Prevention and Left Ventricular Hypertrophy:
- Losartan has shown benefit in reducing stroke risk and regressing LV hypertrophy in hypertensive patients.

Adverse Effects / Insights:

Hypotension and Dizziness:

• Most common with the first dose or when combined with diuretics or other antihypertensives.
• Occurs due to vasodilation and reduced preload/afterload.
• Insight:

Monitor blood pressure regularly, especially after initiation or dose changes.
Advise patients to rise slowly from sitting or lying positions to prevent falls.
Encourage adequate hydration unless contraindicated.

Hyperkalemia:

• Occurs due to decreased aldosterone secretion, leading to reduced potassium excretion.
• Risk increases when used with potassium-sparing diuretics (spironolactone, amiloride), potassium supplements, or renal impairment.
• Clinical Signs: Muscle weakness, palpitations, or cardiac arrhythmias.
• Insight:

Monitor serum potassium and renal function at baseline and periodically.
Teach patients to avoid high-potassium foods (bananas, oranges, salt substitutes).
Report symptoms of muscle weakness or irregular heartbeat.

Angioedema (Rare but Serious):

• Although less common than with ACE inhibitors, ARBs can still cause angioedema, particularly in patients who have experienced it with ACE inhibitors.
• Symptoms: Swelling of the face, lips, tongue, or throat; may cause airway obstruction.
• Insight:

Discontinue immediately if swelling occurs.
Educate patients to seek emergency care if facial or throat swelling develops.

Renal Impairment:

• In patients with bilateral renal artery stenosis, ARBs may cause reduced glomerular filtration and a rise in BUN and creatinine.
• Insight:

Monitor renal function (BUN, creatinine, GFR) before initiation and periodically during therapy.
Stop drug if there is a significant increase in creatinine (>30% from baseline).

Fetal Toxicity:

• ARBs are contraindicated during pregnancy (especially 2nd and 3rd trimesters) due to the risk of:

Fetal renal failure
Oligohydramnios
Pulmonary hypoplasia
Skull and limb deformities
Fetal death
• Insight:
Counsel all women of childbearing potential to use effective contraception.
If pregnancy is detected, stop the drug immediately and inform the healthcare provider.

Other Effects:

• Headache, fatigue, and dizziness (usually mild and transient).
• Rarely, back pain or nasal congestion due to vasodilatory effects.

Monitoring Parameters:

• Blood Pressure: Monitor trends and orthostatic changes to assess therapeutic response.
• Serum Electrolytes: Especially potassium and sodium to detect imbalances.
• Renal Function Tests: BUN, serum creatinine, and estimated GFR.
• Signs of Angioedema: Swelling, difficulty breathing, or hoarseness.
• Daily Weight: Useful for assessing volume status in heart failure patients.

Patient Education:

• Medication Adherence:
Take medication at the same time daily, even if feeling well. Do not stop without medical supervision.

• Postural Safety:
Rise slowly from sitting or lying positions; sit at bedside for a few seconds before standing to prevent dizziness.

• Dietary Guidance:
Avoid potassium supplements and salt substitutes unless prescribed. Maintain a low-sodium diet.

• Symptom Reporting:
Report any facial swelling, difficulty breathing, dizziness, or unusual weakness immediately.

• Pregnancy Precaution:
Avoid pregnancy while on ARBs; inform provider if planning to conceive.

• Avoid NSAIDs:
NSAIDs (ibuprofen, naproxen) may reduce the antihypertensive effect and impair renal function—use only if approved by a provider.

• Lifestyle Reinforcement:
Combine ARB therapy with regular exercise, low-sodium diet, stress reduction, and smoking cessation to maximize cardiovascular benefit.

Take Practice Test on Angiotensin Receptor Blockers (ARBs)

Take Practice Test on Practice Exercise 4

Calcium Channel Blockers (CCBs)

Drug examples:
• Dihydropyridines: Amlodipine, Nifedipine, Felodipine, Nicardipine, Isradipine
• Non-dihydropyridines: Verapamil, Diltiazem

Overview:
Calcium Channel Blockers (CCBs) are a major class of antihypertensive agents that act primarily by blocking the influx of calcium ions (Ca²⁺) through L-type calcium channels found in the smooth muscle of blood vessels, cardiac muscle, and conducting tissue of the heart. Because calcium plays a crucial role in muscle contraction and impulse conduction, inhibition of calcium entry results in smooth muscle relaxation, vasodilation, and reduced cardiac workload.

These drugs are highly effective for hypertension, angina pectoris, and certain cardiac arrhythmias, especially in populations such as older adults and Black patients, who may show less response to ACE inhibitors or ARBs.

Mechanism of Action:
CCBs block the voltage-gated L-type calcium channels on vascular smooth muscle and cardiac myocytes, leading to the following effects:

• Vasodilation: By preventing calcium entry into vascular smooth muscle, CCBs cause arteriolar relaxation, which lowers peripheral vascular resistance (PVR) and reduces blood pressure (BP).

• Decreased Myocardial Contractility: Calcium ions are essential for cardiac muscle contraction. By reducing intracellular calcium, CCBs decrease the force of myocardial contraction, leading to reduced cardiac workload and oxygen consumption.

• Reduced Cardiac Conduction and Heart Rate (non-dihydropyridines):

Verapamil and Diltiazem act on the sinoatrial (SA) and atrioventricular (AV) nodes, slowing impulse conduction and reducing heart rate (negative chronotropic effect).
This makes them useful in supraventricular tachycardias, atrial fibrillation, and angina.

• Increased Coronary Blood Flow: By dilating coronary arteries, CCBs improve oxygen delivery to the myocardium, relieving ischemia and anginal pain.

Pharmacologic Subclasses:

Dihydropyridines (Vascular Selective):
- Drugs: Amlodipine, Nifedipine, Felodipine, Nicardipine
- Primarily act on vascular smooth muscle, producing potent arteriolar vasodilation with minimal cardiac depression.
- They are excellent for treating hypertension, particularly isolated systolic hypertension in elderly patients.
- May cause reflex tachycardia due to rapid vasodilation.
Non-Dihydropyridines (Cardioselective):
- Drugs: Verapamil, Diltiazem
- Have significant effects on cardiac conduction and contractility.
- Used for angina, rate control in atrial fibrillation, and hypertension.
- Should be used cautiously in patients with heart failure, bradycardia, or AV conduction defects.

Primary Actions:
• Reduction of Blood Pressure: Through systemic vasodilation and decreased afterload, leading to a sustained lowering of arterial pressure.
• Relief of Angina Pectoris: Improves myocardial oxygen balance by reducing workload and increasing coronary perfusion.
• Management of Cardiac Arrhythmias: Especially supraventricular tachycardia, atrial fibrillation, and atrial flutter (non-dihydropyridines).
• Preferred Agents for Specific Populations:

Older adults and Black patients often respond well to CCBs compared to ACE inhibitors or ARBs.
Effective in patients with isolated systolic hypertension, common in the elderly due to reduced arterial compliance.

Therapeutic Uses:
• Hypertension (first-line therapy or combination therapy)
• Angina pectoris (stable, variant, and Prinzmetal’s angina)
• Supraventricular tachyarrhythmias (verapamil, diltiazem)
• Raynaud’s phenomenon (due to vasodilation)
• Hypertrophic cardiomyopathy (verapamil)

Adverse Effects / Insights:

• Peripheral Edema:

Most common adverse effect, especially with dihydropyridines like amlodipine and nifedipine.
Caused by preferential dilation of arterioles over venules, leading to fluid leakage into interstitial spaces.
Insight: Elevate legs, monitor for swelling, and notify provider if severe.

• Bradycardia, AV Block, and Heart Failure Exacerbation:

Seen mainly with non-dihydropyridines (verapamil, diltiazem).
Insight: Monitor heart rate and ECG; hold drug if HR < 60 bpm or if heart block develops.
Avoid combining with beta-blockers to prevent excessive cardiac suppression.

• Reflex Tachycardia:

More likely with short-acting nifedipine due to rapid vasodilation.
Insight: Prefer long-acting or sustained-release preparations to minimize risk.

• Constipation:

Especially with verapamil due to decreased smooth muscle motility in the GI tract.
Insight: Encourage high-fiber diet, adequate fluids, and activity.

• Flushing, Headache, Dizziness:

Result from vasodilation and transient hypotension.
Insight: Reassure patients these are usually mild and transient; monitor BP regularly.

• Hypotension and Orthostatic Dizziness:

Particularly during initial dosing or dose escalation.
Insight: Instruct patients to rise slowly and avoid sudden position changes.

• Gingival Hyperplasia:

Chronic use of nifedipine may cause gum overgrowth.
Insight: Encourage good oral hygiene and regular dental visits.

• Hepatotoxicity (rare):

Elevated liver enzymes may occur; monitor liver function periodically.

• Worsening of Heart Failure (non-dihydropyridines):

Due to negative inotropic effects; contraindicated in heart failure with reduced ejection fraction (HFrEF).

Nursing Care and Monitoring:
• Monitor Vital Signs: Assess BP and HR before administration; hold drug if HR < 60 bpm or systolic BP < 100 mmHg (unless prescribed otherwise).
• Assess for Signs of Edema: Especially in ankles, feet, and lower legs.
• Monitor for Cardiac Effects: Observe for bradycardia, irregular pulse, or symptoms of heart block (dizziness, fatigue).
• Evaluate for Therapeutic Effectiveness: BP reduction, relief of anginal pain, or controlled HR in arrhythmia.
• Monitor Liver and Renal Function Tests: For early detection of hepatotoxicity or impaired clearance.
• Monitor ECG in Patients on Verapamil or Diltiazem: To detect PR interval prolongation or AV block.

Patient Education:
• Take medication consistently at the same time each day; do not skip or double doses.
• Avoid Grapefruit Juice: It inhibits CYP3A4 metabolism, increasing serum levels of CCBs and risk of toxicity.
• Report swelling of feet/ankles, slow or irregular heartbeat, or dizziness to healthcare provider.
• Do not discontinue medication abruptly—may cause rebound hypertension or angina.
• Maintain adequate hydration and dietary fiber to prevent constipation.
• Rise slowly from sitting or lying positions to reduce risk of orthostatic hypotension.
• Continue BP monitoring at home; keep a record for evaluation.

Special Considerations:
• Older Adults: Start with lower doses; more sensitive to hypotensive effects.
• Combination Therapy: CCBs may be combined with ACE inhibitors, ARBs, or diuretics for additive BP control.
• Pregnancy and Lactation: Generally avoided; limited safety data available.
• Heart Failure: Avoid non-dihydropyridines; amlodipine may be used cautiously if needed.
• Drug Interactions:

Beta-blockers: Risk of excessive bradycardia and heart block with verapamil/diltiazem.
Digoxin: Verapamil increases digoxin levels; monitor for toxicity.
CYP3A4 inhibitors/inducers: May alter plasma concentrations of CCBs.

Clinical Pearls for Nursing Practice:
• Dihydropyridines (e.g., amlodipine) are preferred for hypertension due to their strong vasodilatory effects and minimal cardiac depression.
• Non-dihydropyridines (verapamil, diltiazem) are preferred for rate control in arrhythmias and angina but should be avoided in heart failure.
• Peripheral edema is not due to fluid overload but to altered capillary dynamics; diuretics often do not resolve it.
• Grapefruit juice can increase serum drug levels—always assess for dietary habits.
• Monitor for additive effects when used with other antihypertensives or CNS depressants.
• Encourage patients to report any severe dizziness, palpitations, or swelling promptly.

Take Practice Test on Calcium Channel Blockers (CCBs)

Take Practice Test on Practice Exercise 5

Adrenergic Antagonists (sympatholytics)

Adrenergic antagonists, also known as sympatholytic drugs, are agents that inhibit or block the effects of the sympathetic nervous system (SNS), which is responsible for the “fight-or-flight” response. By opposing the actions of catecholamines (epinephrine and norepinephrine) at adrenergic receptors, these drugs reduce heart rate, myocardial contractility, and vascular resistance, leading to lowered blood pressure and reduced cardiac workload.

They are classified based on the receptors they act upon:

Beta-adrenergic blockers (β-blockers) – act on β₁ and/or β₂ receptors.
Alpha₁-adrenergic blockers – act on α₁ receptors in blood vessels and smooth muscles.
Alpha₂-adrenergic agonists – act centrally on α₂ receptors in the brainstem to reduce sympathetic outflow.

A. Beta-Adrenergic Blockers (Beta-Blockers)

Drug examples:
• Cardioselective (β₁ only): Metoprolol, Atenolol, Bisoprolol, Esmolol
• Nonselective (β₁ and β₂): Propranolol, Nadolol, Timolol
• Mixed alpha and beta blockers: Carvedilol, Labetalol

Mechanism of Action:

Beta-blockers competitively block β-adrenergic receptors in the heart, kidneys, and vascular smooth muscle.

Cardiac Effects: Blocking β₁ receptors in the heart reduces the effects of sympathetic stimulation → decreased heart rate (negative chronotropic effect), decreased myocardial contractility (negative inotropic effect), and decreased conduction velocity (negative dromotropic effect). These effects collectively lower cardiac output (CO) and blood pressure (BP).
Renal Effects: By blocking β₁ receptors in the juxtaglomerular apparatus of the kidney, beta-blockers inhibit renin release, which suppresses the renin-angiotensin-aldosterone system (RAAS), reducing angiotensin II–mediated vasoconstriction and aldosterone-mediated sodium retention.
Vascular Effects: Long-term use leads to decreased peripheral vascular resistance (PVR), improving overall BP control.
Central Nervous System: Some beta-blockers, like propranolol, cross the blood-brain barrier and can reduce anxiety, tremors, and migraine frequency.

Primary Actions / Therapeutic Uses:

• Hypertension: Reduce BP through lowered cardiac output and suppressed renin release.
• Angina pectoris: Decrease myocardial oxygen demand by reducing HR and contractility.
• Myocardial infarction (MI): Lower post-MI mortality by decreasing arrhythmias and oxygen consumption.
• Heart failure (HF): Carvedilol, metoprolol succinate, and bisoprolol improve survival and reduce hospitalizations in chronic HF.
• Cardiac arrhythmias: Used to control supraventricular tachycardia (SVT), atrial fibrillation, and ventricular arrhythmias.
• Migraine prophylaxis: Propranolol is effective in preventing migraine attacks.
• Anxiety and tremor: Reduce physical symptoms of anxiety such as palpitations and tremors (e.g., propranolol).
• Thyrotoxicosis: Decrease sympathetic overactivity and conversion of T4 to T3.

Adverse Effects / Insights:

• Bradycardia and Heart Block:

Excessive β₁ blockade slows SA and AV nodal conduction.
Insight: Check pulse before administration; hold if HR < 60 bpm. Monitor ECG for AV block.

• Hypotension:

Excessive lowering of BP can cause dizziness or syncope.
Insight: Monitor BP before and after dosing; educate on slow position changes.

• Fatigue and Exercise Intolerance:

Reduced cardiac output can lead to tiredness, especially early in therapy.
Insight: Encourage gradual activity; reassure that fatigue often improves with time.

• Bronchospasm (Nonselective Agents):

Blocking β₂ receptors in bronchial smooth muscle may precipitate bronchoconstriction.
Avoid nonselective agents (e.g., propranolol) in patients with asthma or COPD.

• Masking of Hypoglycemia:

Beta-blockers may conceal symptoms of hypoglycemia (e.g., tachycardia, tremor) in diabetics.
Insight: Educate diabetic patients to monitor blood glucose closely.

• Sexual Dysfunction / Impotence:

A common cause of non-adherence. Offer reassurance and discuss alternative therapy if severe.

• Cold Extremities and Raynaud’s Phenomenon:

Due to peripheral vasoconstriction from unopposed α-adrenergic tone.

• CNS Effects (more with lipophilic agents like propranolol):

Depression, insomnia, vivid dreams, or hallucinations may occur.

• Abrupt Withdrawal:

Sudden discontinuation can cause rebound hypertension, angina, or MI due to upregulation of β receptors.
Insight: Taper gradually over 1–2 weeks under supervision.

Monitoring Parameters:

Heart Rate and BP: Before each dose.
Signs of Heart Failure: Dyspnea, weight gain, edema, fatigue.
Blood Glucose (in diabetics): For hypoglycemia unawareness.
Lung Function: In asthma or COPD patients on cardioselective agents.

Patient Education:

Take medication consistently at the same time daily.
Do not stop abruptly.
Report slow pulse, dizziness, shortness of breath, or swelling.
Avoid alcohol and hot showers that may worsen hypotension.
Monitor pulse at home and record readings.

B. Alpha₁-Adrenergic Blockers

Drug examples:
Prazosin, Doxazosin, Terazosin

Mechanism of Action:

Alpha₁-adrenergic blockers act by competitively inhibiting α₁ receptors located on vascular smooth muscle.

• Vasodilation: Blocking α₁ receptors prevents catecholamine-induced vasoconstriction, leading to arterial and venous dilation, decreased PVR, and reduced BP.
• Relaxation of Smooth Muscle in Prostate and Bladder Neck: Improves urine flow in men with benign prostatic hyperplasia (BPH) by reducing urethral resistance.
• No Reflex Tachycardia: Minimal effect on cardiac output compared to direct vasodilators.

Primary Actions / Therapeutic Uses:

• Hypertension: Adjunctive or second-line therapy; often combined with diuretics or beta-blockers.
• Benign Prostatic Hyperplasia (BPH): Improve urinary symptoms by relaxing bladder outlet and prostatic smooth muscle.
• Raynaud’s Disease: Alleviates peripheral vasospasm.
• Pheochromocytoma (off-label): As preoperative BP control.

Adverse Effects / Insights:

• First-Dose Orthostatic Hypotension:

Marked drop in BP with initial dose due to venous pooling.
Insight: Give first dose at bedtime; monitor BP closely after administration.

• Dizziness, Fainting, Tachycardia:

Due to vasodilation and compensatory reflex sympathetic activation.
Educate patient to rise slowly and sit if dizzy.

• Nasal Congestion:

Secondary to dilation of nasal vessels.

• Fluid Retention:

Activation of RAAS may lead to edema; may need combination with diuretic.

• Headache and Weakness:

Common early in therapy; usually transient.

Nursing Care and Education:

Start with low dose, titrate slowly (“start low, go slow”).
Monitor BP supine and standing.
Advise bedtime dosing for first few doses.
Warn patient to avoid driving or hazardous tasks after first dose.
Monitor for syncope or palpitations; report persistent dizziness.
Evaluate urinary flow improvement in BPH.

C. Alpha₂-Adrenergic Agonists (Centrally Acting Agents)

Drug examples:
Clonidine, Methyldopa, Guanfacine

Mechanism of Action:

These drugs act centrally on α₂-adrenergic receptors in the brainstem (medulla oblongata).

• Decreased Sympathetic Outflow: Activation of α₂ receptors inhibits norepinephrine release, reducing sympathetic tone to the heart and peripheral vessels.
• Decreased HR and CO: The heart receives less sympathetic stimulation, lowering HR, cardiac output, and BP.
• Decreased Peripheral Resistance: Long-term use reduces systemic vascular resistance.

Primary Actions / Therapeutic Uses:

• Hypertension (Resistant or Severe): Effective as adjunctive therapy when other agents fail.
• Hypertensive Emergencies (Clonidine): Rapid BP reduction when administered orally or transdermally.
• Pregnancy-Induced Hypertension (Methyldopa): Safe and preferred agent for chronic hypertension in pregnancy.
• ADHD (Clonidine and Guanfacine): Used in children and adults to reduce hyperactivity and impulsivity.
• Opioid or Nicotine Withdrawal (Clonidine): Mitigates sympathetic symptoms such as sweating, restlessness, and anxiety.

Adverse Effects / Insights:

• Sedation and Drowsiness:

Most common; due to central nervous system depression.
Insight: Caution with driving or machinery; give at bedtime.

• Dry Mouth (Xerostomia):

Caused by reduced salivary secretion.
Insight: Offer frequent sips of water, sugar-free gum, and good oral hygiene.

• Bradycardia:

From reduced sympathetic stimulation; monitor pulse regularly.

• Rebound Hypertension:

Sudden discontinuation leads to surge in sympathetic activity and severe BP elevation.
Insight: Taper dose gradually; never stop abruptly.

• Depression and Fatigue (Long-Term Use):

Monitor mood changes; may require discontinuation.

• Orthostatic Hypotension:

Especially when combined with other antihypertensives; rise slowly.

• Skin Irritation (Clonidine Patch):

Rotate sites weekly to prevent dermatitis.

Nursing Care:

Monitor BP, HR, and signs of orthostatic changes.
Educate patient to change positions slowly.
If using transdermal clonidine, ensure patch is changed every 7 days, applied to hairless area, and removed before MRI.
Reinforce adherence: missing doses can precipitate rebound hypertension.
Advise on oral care and hydration for dry mouth.
Evaluate mental status for depression or sedation.

Take Practice Test on Adrenergic Antagonists (sympatholytics)

Take Practice Test on Practice Exercise 6

Direct Vasodilators

Direct vasodilators are a distinct group of antihypertensive agents that act directly on the smooth muscle of blood vessels, causing relaxation and arteriolar dilation. Unlike other antihypertensive drug classes that work through neural or hormonal modulation (such as beta-blockers or ACE inhibitors), direct vasodilators produce their effects through local action on vascular smooth muscle cells, thereby reducing systemic vascular resistance (SVR) and lowering afterload.

Because they can trigger powerful reflex compensatory mechanisms—including tachycardia and sodium/water retention—they are usually reserved for moderate to severe or resistant hypertension and are often used in combination with beta-blockers and diuretics.

Drug examples:

• Hydralazine (Apresoline) – Prototype direct vasodilator for chronic hypertension
• Minoxidil (Loniten) – More potent, used for severe refractory hypertension
• Sodium Nitroprusside (Nitropress) – Intravenous vasodilator for hypertensive emergencies
• Diazoxide – Occasionally used IV for emergency BP control (rarely used now due to adverse effects)

Mechanism of Action:

Hydralazine and Minoxidil:
These drugs act directly on arteriolar smooth muscle, causing relaxation through poorly defined mechanisms. The result is a reduction in peripheral resistance and arterial pressure, leading to afterload reduction and improved cardiac output.

Hydralazine is thought to work by interfering with calcium ion movement in vascular smooth muscle, leading to inhibition of contraction.
Minoxidil opens potassium channels, hyperpolarizing smooth muscle cells, which prevents calcium influx and maintains vasodilation.

Sodium Nitroprusside:
This agent releases nitric oxide (NO) in the bloodstream, which stimulates cyclic guanosine monophosphate (cGMP) production in smooth muscle cells, causing profound vasodilation of both arteries and veins.

Physiological Effects:

• Arteriolar Dilation: Reduces systemic vascular resistance → lowers afterload → decreases BP.
• Venous Dilation (minimal with hydralazine): Since venous tone is largely unaffected, reflex tachycardia occurs as the heart attempts to compensate for the sudden drop in BP.
• Increased Cardiac Output: Due to baroreceptor activation and increased sympathetic drive.
• Enhanced Renin Release: Activation of RAAS causes sodium and water retention, potentially leading to edema if not managed with a diuretic.

Primary Actions / Therapeutic Uses:

1. Hypertension (Moderate to Severe):

Used when BP is not adequately controlled by first-line agents (diuretics, ACE inhibitors, calcium channel blockers).
Usually combined with a beta-blocker (to counter reflex tachycardia) and a diuretic (to prevent fluid retention).

2. Hypertensive Emergencies (IV Sodium Nitroprusside):

Produces an immediate BP reduction within seconds and is easily titratable.
Used in hypertensive crises, aortic dissection, and acute heart failure with elevated afterload.
Requires continuous blood pressure monitoring due to risk of severe hypotension.

3. Heart Failure (Hydralazine + Isosorbide Dinitrate Combination):

This combination provides balanced vasodilation (arterial via hydralazine, venous via isosorbide dinitrate).
Shown to improve survival and symptoms in African American patients with heart failure, especially when added to standard therapy (ACE inhibitors and beta-blockers).

4. Alopecia (Minoxidil topical form):

Minoxidil’s side effect of promoting hair growth led to its topical use for male and female pattern baldness.

Adverse Effects / Insights:

Hydralazine (Apresoline):

Common Adverse Effects:
• Reflex Tachycardia and Palpitations: Sudden vasodilation triggers baroreceptor-mediated sympathetic activation.
• Flushing, Headache, and Dizziness: Due to sudden changes in vascular tone.
• Nausea and GI Upset: Common early in therapy.
• Fluid Retention and Peripheral Edema: Secondary to RAAS activation; may require concurrent diuretic.
• Lupus-Like Syndrome:

Occurs with long-term use or high doses.
Characterized by arthralgia, myalgia, fever, rash, and positive ANA test.
More common in slow acetylators (genetic predisposition).
Insight: Monitor for joint pain, fatigue, rash; discontinue if suspected.

Nursing Care and Implications:

Monitor BP and HR before and during therapy; watch for reflex tachycardia.
Assess for fluid overload: monitor daily weight, intake/output, and edema.
Administer with food to enhance absorption and minimize GI upset.
Avoid abrupt discontinuation to prevent rebound hypertension.
Educate patient: report persistent headache, chest pain, palpitations, or joint pain.
Combination therapy: Usually prescribed with a beta-blocker (e.g., metoprolol) and a diuretic (e.g., hydrochlorothiazide).

Minoxidil (Loniten):

Adverse Effects:
• Severe Fluid Retention and Edema: Often requires concurrent diuretic.
• Reflex Tachycardia: Can exacerbate angina or precipitate MI.
• Hypertrichosis (Excessive Hair Growth): Notable on face, arms, and back—basis for its use in topical hair growth formulas.
• Pericardial Effusion: Rare but serious; can progress to tamponade.

Insights:

Reserved for severe refractory hypertension.
Always combine with beta-blocker and loop diuretic.
Monitor HR, BP, weight, and signs of fluid retention.
Educate patient on possible cosmetic hair growth.

Sodium Nitroprusside (Nitropress):

Mechanism and Use:

Powerful arterial and venous vasodilator used IV in hypertensive emergencies.
Onset: Seconds; Duration: 1–2 minutes after discontinuation.
Acts via nitric oxide release, increasing cGMP in vascular smooth muscle.

Adverse Effects:
• Severe Hypotension: Rapid drop in BP can cause ischemia in vital organs if not titrated carefully.
• Cyanide or Thiocyanate Toxicity:

Nitroprusside is metabolized to cyanide, detoxified in the liver to thiocyanate.
Risk increases with prolonged use (>48 hrs) or in renal/hepatic impairment.
Symptoms: confusion, muscle spasms, metabolic acidosis, and almond odor on breath.
• Nausea, Vomiting, Restlessness: Mild but common during rapid infusion.

Insights:

Continuous IV infusion in an ICU setting only.
Use dedicated line with infusion pump; monitor BP continuously (arterial line preferred).
Protect solution from light (wrap IV bag/tubing with opaque material).
Limit duration to <48 hours; monitor cyanide and thiocyanate levels if prolonged use is unavoidable.
Monitor renal and hepatic function.
Do not mix with other drugs in the same line.

Take Practice Test on Direct Vasodilators

Take Practice Test on Practice Exercise 7

Summary

1. Diuretics – Thiazides, Loops, Potassium-sparing

Action: ↑ Na⁺/H₂O excretion → ↓ blood volume → ↓ BP; long-term ↓ PVR.
Uses: First-line for mild–moderate HTN; heart failure, CKD, edema.
Key AE: Electrolyte imbalances, orthostatic hypotension, ototoxicity (loops), gynecomastia (spironolactone).
Nursing: Monitor BP, electrolytes, weight; educate on hydration, K⁺ intake, postural safety.

2. ACE Inhibitors – Captopril, Lisinopril, Enalapril

Action: Block ACE → ↓ angiotensin II → vasodilation, ↓ aldosterone; ↑ bradykinin.
Uses: HTN, heart failure, post-MI, diabetic nephropathy.
Key AE: Cough, hyperkalemia, angioedema, fetal toxicity.
Nursing: Monitor BP, renal function, electrolytes; avoid NSAIDs, report swelling/cough, pregnancy warning.

3. ARBs – Losartan, Valsartan, Irbesartan

Action: Block AT₁ receptor → ↓ vasoconstriction & aldosterone; no bradykinin.
Uses: HTN, heart failure, diabetic nephropathy, post-MI.
Key AE: Hypotension, hyperkalemia, angioedema (rare), fetal toxicity.
Nursing: Monitor BP, renal function, electrolytes; postural safety, pregnancy caution.

4. Calcium Channel Blockers (CCBs) – Dihydropyridines (amlodipine), Non-dihydropyridines (verapamil, diltiazem)

Action: Block Ca²⁺ channels → vasodilation; non-DHP ↓ HR & contractility.
Uses: HTN, angina, arrhythmias, isolated systolic HTN.
Key AE: Peripheral edema, bradycardia, AV block, reflex tachycardia, constipation.
Nursing: Monitor BP/HR/ECG; educate on postural changes, hydration, grapefruit interactions.

Take Practice Test on Summary

Take Practice Test on Comprehensive Questions

Naxlex

Videos

Click here to login